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Post-transcriptional modifications including A-to-I RNA editing and alternative 
splicing are important mechanisms for generating molecular diversity of mammalian 
ion channels and receptors. Here, we discover RNA editing within CaV1.3 transcripts 
that encode Ca2+ channels that are known for low voltage activated Ca2+-influx and 
neuronal pacemaking. Significantly, RNA editing occurs within the IQ domain, a 
calmodulin-binding site mediating inhibitory Ca2+-feedback (CDI) on the channels. 
RNA editing of the CaV1.3 IQ domain is CNS-specific, requires RNA adenosine 
deaminase 2 (ADAR2), and is evolutionally conserved from human, rat to mouse. 
Functionally, edited CaV1.3 channels exhibit strong attenuation of CDI, and neurons 
in the suprachiasmatic nucleus show higher frequencies of repetitive action potential 
activity and calcium spikes in wildtype versus ADAR2-/- knockout mice. Apart from 
RNA editing, the transcripts of CaV1.3 channels are extensively alternatively spliced 
at exons coding for IS5-IS6, I-II loop and IVS3-IVS4. Alternative splicing in the 
IS5-IS6, I-II loop significantly affect the activation potential of the channel while 
IVS3-IVS4 splicing alters the channel sensitivity towards dihydropyridine inhibition. 
Tissue selective expression of different splice isoforms therefore customizes channel 
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1.1 The family of voltage-gated calcium channels 
Voltage gated calcium channels (CaV) open in response to membrane 
depolarization to allow entry of Ca2+ ions that is critical to initiate a wide range of 
physiological processes (Berridge et al., 2000). The CaV channels are 
hetero-oligomeric membrane complexes composed of a pore-forming α1-subunit and 
auxiliary subunits including β, α2δ and/or γ-subunit (Catterall, 2000). Among all the 
subunits, the α1-subunit (190 to 250 kDa) is the largest and is also the main 
determinant of the biophysical and pharmacological properties of the channel while 
the associating auxiliary subunits serve to modulate channel properties. 
1.1.1 The subunit composition of CaV channels 
This principal α1-subunit is composed of four homologous membrane 
spanning domains (I-IV) and each of them comprises six transmembrane segments 
(S1-S6) and a re-entrant loop between S5 and S6 (Figure 1.1). While the S1-S4 
segments constitute the main voltage sensing mechanism of the channel (Swartz, 
2008), the S5, S6 segments and the re-entrant loop between them form the pore with 
an ion selectivity filter (Catterall, 2000). On the other hand, the distal segments of S6 
function importantly as the intracellular gate of the channel (Liu et al., 1997; Xie et al., 
2005). In addition, the intracellular N-terminus, C-terminus and the loops linking 
different domains, including I-II loop, II-III loop and III-IV loop, harbor various 
signature motifs for interaction with various proteins which serve to modulate channel 
functions (Pragnell et al., 1994; Peterson et al., 1999; Liu et al., 2004; Zhang et al., 
2005; Baroudi et al., 2006; Ramadan et al., 2009) 
The interaction of the pore subunit with various auxiliary subunits exerts 
additional regulations on channel properties. Co-expression with the β-subunit 
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promotes the surface expression of the channel (Altier et al., 2011) and different 
β-subunits result in different shifts of channel gating and different kinetics of voltage 
dependent inactivation (Lacerda et al., 1991; Cens et al., 1999). In comparison, 
co-expression of α2δ-subunit (Klugbauer et al., 1999) and occasionally γ-subunit 
(Letts et al., 1998) may also modulate expression and gating properties, although to a 
lesser extent.   
1.1.2 The classification of different CaV subtypes 
The mammalian CaV α1 sub-family comprises 10 genes and each identifies 
one subtype of CaV channels. The ten voltage-gated calcium channels are categorized 
into three groups including CaV1 (L-type), CaV2 (P-type, N-type and R-type) and 
CaV3 (T-type) based on their degree of sequence conservation. Further 
electrophysiological characterization classified CaV1 and CaV2 channels as high 
voltage activated (HVA) channels and CaV3 channels as low voltage activated (LVA) 
channels according to their activation thresholds. Four types of L-type calcium 
channel CaV1.1, CaV1.2, CaV1.3, CaV1.4, each containing the α1S, α1C, α1D and α1F 
subunit respectively, are distinguished from the other 6 CaV channels by their slowly 
inactivating Ba2+ currents and their selective sensitivity to  dihydropyridines (DHP), 
phenylalkylamines (PAAs) and benzothiazepines (BTZs) (Catterall, 2000).  
1.2 The physiological roles and properties of CaV1.3 channels 
Among the four L-type channels, CaV1.3 channel plays a significant role in 
gating low-threshold-activating Ca2+ current that underlies neuronal pacemaking 
(Pennartz et al., 2002; Chan et al., 2007), excitation-transcription coupling (Zhang et 
al., 2005; Zhang et al., 2006; Wheeler et al., 2008) normal synaptic function 
(Sinnegger-Brauns et al., 2004; Day et al., 2006), cardiac rhythm (Platzer et al., 2000) 
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and hormone secretion (Marcantoni et al., 2007). It is widely expressed in the central 
nervous system, cochlea, sinoatrial node (SAN) of the heart and in the endocrine 
system including the beta cells of the pancreas and chromaffin cells of the adrenal 
gland.  
1.2.1 The functional roles of CaV1.3 inferred from CaV1.3-/- knockout mice 
Much of the knowledge regarding the functional roles of CaV1.3 has been 
gained from the characterization of the CaV1.3 knockout mice (Platzer et al., 2000). 
The CaV1.3 channels conduct significant inward current at the operating range of the 
hair cells of the cochlea and the pacemaking cells in SAN due to their low activation 
threshold (Koschak et al., 2001; Xu and Lipscombe, 2001). Correspondingly, deletion 
of CaV1.3 resulted in congenital deafness due to almost complete absence of calcium 
current in the inner hair cell (Platzer et al., 2000). In addition CaV1.3-/- mice exhibit 
bradycardia as a result of SAN dysfunction (Platzer et al., 2000). More recent reports 
of the same CaV1.3-/- mice revealed other subtle phenotypic changes. For example, 
CaV1.3 deletion impaired the consolidation of conditioned fear (McKinney and 
Murphy, 2006) due to compromised long term potentiation of the amygdala 
(McKinney et al., 2009).  In line with the findings in CaV1.3-/- mice, a 
loss-of-function mutation of human CaV1.3 was recently characterized in two 
consanguineous Pakistani families (Baig et al., 2011). The mutation resulted in 
production of non-conducting CaV1.3 channels and expectedly subjects homozygous 
for such mutations suffered from congenital deafness and SAN dysfunction (Baig et 
al., 2011). However, other clinical features in human due to loss of CaV1.3 current are 
yet to be characterized.   
1.2.2 The biophysical properties of CaV1.3 channels and modulation 
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The property of the CaV1.3 current is defined by its gating mechanisms. 
While the low activation threshold appears to be an intrinsic property of the CaV1.3 
channels, which is still poorly understood, a variety of feedback mechanisms that 
inactivate the channel in response to either voltage-induced conformational change 
(voltage dependent inactivation [VDI]) or elevation of intracellular [Ca2+] (Ca2+ 
dependent inactivation [CDI]) have been well characterized. The process of VDI is 
initiated by the voltage-dependent conformational rearrangement of voltage-sensing 
domain comprising S1-to-S4 segments (Swartz, 2008) leading to subsequent opening 
of the S6 gate (Liu et al., 1997; Xie et al., 2005) and finally the occlusion of the gate 
by the I-II loop in a ‘hinge lid’ mechanism. Interestingly, a recently identified “shield’ 
that repels the closure of the channel gate by the I-II loop ‘lid’ appears to be a unique 
feature of the CaV1.3 channel (Tadross et al., 2008) allowing the channel to remain 
open despite prolonged activation. In comparison, CDI (calcium dependent 
inactivation) is a negative feedback mechanism arising from the influx of calcium. 
Calcium ions when bound to the bi-lobe calcium sensor, calmodulin (CaM) that is 
constitutively tethered to the preIQ-IQ domain of the C-terminus of the channel, 
trigger a series of conformational changes which lead eventually to channel 
inactivation (Peterson et al., 1999; Zuhlke et al., 1999; Pitt et al., 2001; Erickson et al., 
2003; Mori et al., 2004; Dick et al., 2008). Although the intermediate steps of CDI 
remain elusive, a more recent study indicated that the final stage of CDI involved 
allosteric regulation of the opening of the S6 gate (Tadross et al., 2008).  
Fitting with the diverse functional roles of the channel, the gating of CaV1.3 
channel is often differentially modulated in a tissue-specific manner. The native 
CaV1.3 current in pancreatic β-cells and SAN cells displayed substantial inactivation 
(Plant, 1988; Mangoni et al., 2003) matching the profile of CaV1.3 channels 
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characterized in heterologous systems (Xu and Lipscombe, 2001; Song et al., 2003). 
In contrast, ICa recorded from hair cells in cochlea showed little inactivation (Platzer 
et al., 2000; Song et al., 2003) suitably allowing for persistent cellular activity even in 
the presence of the prolonged sound stimulus (Shen et al., 2006; Yang et al., 2006). 
Several mechanisms have been proposed to explain the tissue-specific specialization 
of CaV1.3 channels. Taking cochlea as an example, selective co-localizations of 
CaV1.3 channels with various proteins such as syntaxin, CaBP (calcium-binding 
protein) and Rab3-interacting molecule (RIM) have been proposed to slow down 
channel inactivation (Song et al., 2003; Yang et al., 2006; Gebhart et al., 2010), 
although none of them have been conclusively shown in the native system. 
Alternatively, study by Shen et al., 2006 identified an outer hair cell (OHC) specific 
splice variant of CaV1.3 channels with disrupted IQ domain due to half truncation and 
frame-shift of exon 41. As the IQ domain is essential for calmodulin-mediated CDI, 
dominant expression of such a splice variant selectively in OHC (Shen et al., 2006) 
therefore partly explains the slow inactivating Ca2+ current that was observed. It is 
thus interesting that tissue specific post-transcriptional modification, for example 
alternatively splicing, could potentially generate channel variants of customized 
properties to suit different physiological needs. However till now, post-transcriptional 
modifications of CaV1.3 channels by mechanisms such as alternatively splicing and 
RNA editing remain largely uncharacterized.    
1.3 Extensive alternative splicing pattern in α1D transcripts 
1.3.1 The mechanism of alternative splicing 
Alternative splicing is a process by which the exons of primary RNA 
transcripts are assembled and reconnected in multiple ways thus enabling the 
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production of different protein isoforms that possibly differ in structure, function, 
localization and other properties (Black, 2003; Matlin et al., 2005). Different 
mechanisms for alternative splicing exist including utilization of: (i) cassette exon - an 
alternate exon could either be included or excluded; (ii) mutually exclusive exon - one 
or more adjacent exons are spliced such that only one exon is retained at a time; (iii) 
different 5’ or 3’ alternative splice acceptor or donor sites allowing for either the 
lengthening or shortening of a particular exon; (iv) intron retention where an intron 
was included in the mature mRNA and (v) alternative promoter or poly-A site.   
1.3.2 The impact of alternative splicing on CaV1.3 channel function 
The CaV1.3 channels are subject to extensive alternative splicing as 
summarized in Figure 1.1 and Table 1. A total of 14 exons have been reported to be 
alternatively spliced and some of them showed tissue and even species specific 
distribution. Despite the rich assortment of channel isoforms with possibly different 
functional characteristics, the functional impact of alternative splicing of the α1D 
transcript is still not fully understood.  
Alternative splicing of the amino terminus (N-terminus) was known to affect 
the current density of CaV1.3 channels (Klugbauer et al., 2002; Xu et al., 2003). 
Inclusion of either exon 1a (Hui et al., 1991; Seino et al., 1992; Williams et al., 1992) 
or 1b (Klugbauer et al., 2002) has been reported in mouse. Exon 1b appears to be 
mouse specific as NCBI database search only detects exon 1b in the mouse but not in 
human or rat genomes. Although both splice variants support functional currents with 
similar gating properties in heterologous expression system, exon 1a conferred much 
larger current density as compared to exon 1b (Klugbauer et al., 2002; Xu et al., 2003). 
In rat and human, exon 1a appears to be constitutively expressed.   
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The IS6, IIIS2 and IVS3 segments of CaV1.3 are encoded by three pairs of 
mutually exclusive exons including exons 8/8a, 22/22a and 31/31a respectively. 
Interestingly, CaV1.2 channels display the same splicing patterns in the 
abovementioned regions and relatively high sequence conservation were observed 
between CaV1.3 and CaV1.2 channels in these three pair of mutually exclusive exons 
(Figure 1.2). The alternative splicing in IS6, IIIS2 and IVS3 segments of CaV1.2 was 
known to alter the sensitivity of the channels towards DHP inhibition with exons 8, 22 
and 31conferring higher drug sensitivity (Liao et al., 2005). In contrast, the functional 
impacts these three pairs of mutually exclusive exons have on CaV1.3 channels are 
less well known. Interestingly, Koschak et al., 2001 reported that a α1D channel 
isoform containing exon 8a cloned from human pancreatic tissue failed to express in 
transiently transfected tsA-201 cells and lack any functional currents while replacing 
exon 8a with exon 8 in the same construct produced functional channels. In 
comparison, a rat brain CaV1.3 channel isoform expressing exon 8a supported robust 
current in transfected Xenopus oocytes (Xu and Lipscombe, 2001). Exon 8a of both 
human and rat share 100% sequence similarity and it is therefore unclear why 
different heterologous systems could affect channel expression. Exon 22a of CaV1.3 
appeared to be expressed specifically to rat organ of corti with unknown functional 
role (Ramakrishnan et al., 2002) while exon 22 is constitutively expressed in other 
tissues. Lastly although exon 31 and 31a in CaV1.3 are both ubiquitously expressed in 
the brain, their properties remain uncharacterized.  
The I-II loop region of CaV1.3 contains three splice variations including 
alternate exon 9*, 11 and 13. Exon 9* (Ramakrishnan et al., 2002) and 13 (Ihara et al., 
1995) were identified in the rat organ of corti and pancreas respectively with 
uncharacterized functional impact (Table 1). On the other hand exon 11 is more 
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ubiquitously expressed (Table 1) in brain and pancreas and deletion of exon 11 was 
found not to affect the channel gating of CaV1.3 (Xu and Lipscombe, 2001). Inclusion 
of exon 9* introduces 26 amino acids into the I-II loop of the Cav1.3 channels. 
Sequence of CaV1.3 exon 9* in the hair cell of chicken contains a consensus sequence 
of serine surrounded by four basic amino acid residues and is therefore a potential 
substrate for protein kinase (Ramakrishnan et al., 2002). In contrast, no such 
consensus site was found in the exon 9* of rat or human CaV1.3 (Ramakrishnan et al., 
2002). While exon 11 and 13 are specific to CaV1.3, exon 9* are found in both CaV1.2 
and CaV1.3 channels, although exon 9* in the two channels display poor sequence 
conservation (Figure 2). Deletion of exon 9* in CaV1.2 channels was found to 
specifically result in hyperpolarizing shift of voltage-dependent activation in smooth 
muscle (Liao et al., 2004). 
The alternate exon 32 encodes part of the extracellular loop between IVS3 
and IVS4. Inclusion or exclusion of exon 32 in CaV1.3 channels has no effect on the 
gating properties of the channel and neither was sensitivity towards nitrendipine 
significantly changed (Xu and Lipscombe, 2001). In comparison, CaV1.2 channels 
expressing exon 33, equivalent of exon 32 of CaV1.3, showed significant depolarized 
shift in the window current and diminished sensitivity towards DHP (Zuhlke et al., 
1998; Liao et al., 2007). However poor sequence conservation is found between exon 
33 of CaV1.2 and exon 32 of CaV1.3.  
The carboxyl-terminus (C-terminus) of CaV1.3 represents another hotspot of 
alternative splicing that has been more extensively characterized. Alternative splicing 
at exon 41 and mutually exclusive exons 42 and 42a has been shown to regulate the 
CDI of the channel. Truncation of exon 41 (half exon 41) due to the alternative usage 
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of splice acceptor site in exon 41 resulted in complete removal of the IQ domain and 
early termination of the C-terminus (Shen et al., 2006). Although functional current 
could still be observed, deletion of IQ domain resulted in complete elimination of CDI 
(Shen et al., 2006). Selective localization of half exon 41 in cochlear outer hair cell 
(OHC) (Shen et al., 2006) corroborated the previous observation of slowly 
inactivating native CaV1.3 current recorded in hair cells, highlighting the tissue 
specific role of such splice isoform in supporting the normal function of the cochlea.     
Further downstream, alternative usage of either exon 42 or 42a gives rise to 
long form (LF) or short form (SF) CaV1.3 channels respectively (Figure 1.1). The stop 
codon in exon 42a results in expression of only 6 amino acids immediately after exon 
41 and therefore the early termination of C-terminus. Although both variants are 
ubiquitously expressed in the brain, the LF channels displays distinctive properties 
such as more depolarized-shifted window current, higher expression, lower current 
density and significantly diminished CDI (Singh et al., 2008). The attenuated CDI in 
the long-form was later explained by the presence of the CDI-inhibiting module (ICDI) 
domain at the distal carboxyl terminal which actively competed with calmodulin for 
the binding to the IQ domain (Liu et al., 2010). The anchoring of calmodulin to the 
preIQ-IQ domain is critical for CaM-modulated channel inactivation (Erickson et al., 
2003; Van Petegem et al., 2005). The attenuated binding between calmodulin and 
CaV1.3 channel therefore results in much slower channel inactivation. Consistently, 
the absence of ICDI domain in short-form channels due to the early termination of 
C-terminus leads to fast CDI. In contrast to these more recent findings, the rat 
long-form CaV1.3 channel construct generated by Xu et al., 2001 (Table 1) displayed 
surprisingly similar gating properties and even similar kinetic of CDI as short-form 
(Xu and Lipscombe, 2001; Liu et al., 2010). However, recent data from our laboratory 
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revealed a possible cloning error in the long form construct reported by Xu et al., 
2001, after extensive sequencing of the C-terminus of rat brain α1D transcripts 
(unpublished data). The mutation in the long-form construct resulted in a valine to 
alanine change at amino acid position 2123 in the ICDI domain. Subsequent 
correction of alanine to valine resulted in the CaV1.3LF A2123V construct that now 
restored major functional effects of ICDI domain including slower CDI and more 
positive window current as compared to short-form. The rat short-form CaV1.3SF and 
corrected long-form CaV1.3LF A2123V construct were then used consistently as baseline 
for further functional characterization of electrophysiological properties of CaV1.3 
channels.  
Furthermore, half truncation of exon 42 due to the alternative use of splice 
donor site results in frame-shifting and early termination of C-terminus (Seino et al., 
1992; Williams et al., 1992). Expectedly the exclusion of ICDI domain in such a 
splice isoform would support rapid CDI similar to that of short-form CaV1.3 channels.  
Apart from regulation of CDI, the truncation of C-terminus due to half exon 
41, inclusion of exon 42a and half 42 has additional functional implications. Firstly, 
early truncation of the C-terminus effectively excludes two consensus sites for PKA 
activity. The two sites, identified using mass spectrometry, include serine 1743 and 
serine 1816 located in exon 43 (Ramadan et al., 2009). Phosphorylation of CaV1.3 
channels by PKA was known to substantially increase CaV1.3 current which 
potentially underlies the sympathetic control of heart rate (Qu et al., 2005). The 
C-terminal alternative splicing of the α1D transcripts, particularly in SAN, could 
therefore regulate the responsiveness of heart rate to the regulation by activation of 
β-adrenergic receptors via cAMP-dependent PKA. Secondly shortening of CaV1.3 
  12
C-terminus omits a C-terminal PDZ motif which is crucial for interaction with 
scaffold protein Shank (Zhang et al., 2005). Such interaction results in postsynaptic 
clustering of long form CaV1.3 channels and was later found to be important for 
processes such as CaV1.3 dependent phosphorylated cAMP response element-binding 
protein (pCREB) signaling (Zhang et al., 2005) and G-protein modulation of CaV1.3 




Figure 1.1 Hypothetical transmembrane topology of CaV1.3 α1 subunit. Outlined are four domain 
repeats, I – IV, each composed of six transmembrane segments, S1 – S6. Mutually exclusive exons 
are indicated by open boxes while alternate exons are represented by bold solid lines. The 









Table 1.1 Summary of alternatively spliced exons identified in CaV1.3 channels, functional impacts and species and tissues where the spliced exons were identified.  
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Figure 1.2 Comparison of sequence conservation between CaV1.2 and CaV1.3 channels in the 
alternatively spliced exons. Mutually exclusive exons 8/8a, 22/22a and 31/31a display relative 
high sequence conservation between CaV1.2 and CaV1.3 channels while low sequence 
conservation is observed in exon 9* and 32. Exon 32 of CaV1.3 is equivalent of exon 33 of CaV1.2 
Sequence discrepancies are highlighted in red. The membrane spanning regions IS6, IIIS2 and 






1.4 A-to-I RNA editing 
As compared to alternative splicing, A-to-I RNA editing allows for single 
nucleotide recoding of primary RNA transcript which could also alter the expression 
and functional properties of the resulting protein (Keegan et al., 2001). Initially 
known for unwinding double-stranded RNA or helicase activity (Bass and Weintraub, 
1987; Rebagliati and Melton, 1987), such mechanism has attracted gradual attention 
for amplifying the genomic coding ability as more and more editing substrates were 
discovered with altered protein functions.   
1.4.1 Adenosine Deaminase Acting on RNA (ADARs) 
A-to-I RNA editing is mediated by a family of enzymes known as Adenosine 
Deaminase Acting on RNA (ADARs) which are double-stranded RNA specific 
enzymes containing multiple copies of N-terminal double-stranded RNA binding 
motifs (dsRBM) and a conserved C-terminal catalytic adenosine deaminase domain. 
Three members of this family have been discovered in mammals including ADAR1, 
ADAR2 and ADAR3. While ADAR1 and ADAR2 are expressed ubiquitously and 
show overlapping specificity, the expression of ADAR3 is restricted to brain and has 
yet no known target (Melcher et al., 1996). The ADARs work by recognizing partially 
or completely double-stranded RNA structure prior to catalyzing hydrolytic 
deamination at C6 position of specific adenine base thus converting adenosine to 
inosine. As inosine was decoded as guanosine by the translational machinery, A-to-I 
editing at the coding sequence of the mRNA could potentially change the codon 
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meaning leading to variation in the sequence of the resulting protein. In comparison, 
RNA editing at the untranslated regions such as the intron may also impact on the 
other aspects of RNA functions such as splicing due to the creation of a new splice 
site (Rueter et al., 1999). Above all, RNA editing supposedly precedes alternative 
splicing (Seeburg, 2000; Keegan et al., 2001) and may play an important role for 
subsequent processing of pre-mRNA by the spliceosome. Disruption of base-pairing 
of RNA duplex via editing serves to facilitate the subsequent unwinding of RNA and 
the recognition of splice sites by the splicing machinery (Seeburg, 2000). Supporting 
this notion, deletion of ADAR2 was found to result in accumulation of un-spliced 
GluR-B mRNA, a well known target of ADAR2 in the brain (Higuchi et al., 2000).  
1.4.2 Functional impact of A-to-I RNA editing 
Most of the common targets of A-to-I RNA editing by ADARs characterized 
so far are ion channels and neurotransmitter receptors in the mammalian nervous 
system (Bass, 2002). Editing of AMPA/kainate-type glutamate receptors (GluRs) 
alters Ca2+ permeability or agonist desensitization, while editing of serotonin 2C 
receptors at five closely spaced sites modulates G-protein signaling (Burns et al., 1997; 
Seeburg et al., 1998). A more recent discovery revealed that editing of KV1.1 channel 
enhanced the recovery from inactivation (Bhalla et al., 2004) and edited GABAA-α3 
receptor displayed both smaller current amplitude and altered gating kinetic (Ohlson 
et al., 2007; Rula et al., 2008).   
Functionally, ADAR2 is responsible for RNA editing that recodes a 
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glutamine to arginine (Q-to-R) change in the selectivity filter of GluR-B subunits of 
AMPA receptor. Editing at Q-to-R site of GluR-B is close to 100% in wildtype mice 
(Higuchi et al., 2000). AMPA receptor containing the genomic-coded GluR-BQ 
subunit are permeable to Ca2+ influx while the edited GluR-B subunit harboring 
arginine at the same position (GluR-BR) renders low Ca2+ permeability of the channel 
(Kohler et al., 1993). Consequently, ADAR2 knockout mice exhibit concomitant 
epilepsy and death at P20 possibly due to increased Ca2+ permeability and fittingly, 
the lethal phenotype was shown to be fully rescued by constitutive expression of 
GluR-BR/R in ADAR2-/-/GluR-BR/R mice (Higuchi et al., 2000).   
Despite having normal appearance and life-span similar to the wildtype, 
interestingly, ADAR2-/-/GluR-BR/R mice exhibit additional deficits in several 
neurological processes (Horsch et al., 2011). Firstly, more rearing activity in the open 
field observed in ADAR2 KO mice correlated with a decreased emotionality and 
reactivity to novelty while a significant reduction in acoustic startle response 
indicated a general deficit in sensorimotor function (Horsch et al., 2011). Lastly, 
transcript profiling of the KO mice brain revealed altered expression in genes 
implicated in processes such as neuroprotection, synaptic trafficking and activity 
mediated modification of postsynaptic density (Horsch et al., 2011). Therefore, given 
the high inosine content of mRNA in neural tissue (Paul and Bass, 1998), it is likely 
that numerous other editing substrates remain to be identified in the mammalian brain. 
In particular, we wonder if editing could fine-tune the CDI of CaV1.3 channels. The 
Ca2+ feedback regulation would be an especially attractive target for editing, as 
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structure-function analysis reveals that even single amino-acid substitutions at critical 
channel hotspots can markedly alter modulatory properties (Zuhlke et al., 2000; Dick 
et al., 2008; Tadross et al., 2008), and such regulation impacts functions as diverse as 
neurotransmitter release, neuronal pacemaking, neurite outgrowth, and gene 
expression (Dunlap, 2007). 
1.5 Brief introduction of the findings 
Here we characterized the functional impact of both A-to-I RNA editing and 
alternative splicing on CaV1.3 channel properties. The first part of the thesis revealed 
the existence of ADAR2-mediated RNA editing of the IQ domain of CaV1.3 channels. 
This editing event appears specific to the central nervous system and evolutionarily 
conserved from mice, rat to human. An RNA duplex structure formed between edited 
site and intronic complementary sequence was predicted by in silico structure 
modeling and subsequently experimentally validated. Functionally, editing in the IQ 
domain substantially slows down CDI. The repetitive action potential activity and 
calcium spikes recorded from neurons in the suprachiasmatic nucleus show higher 
frequencies in wildtype versus ADAR2 knockout mice, highlighting one of the 
possible neurophysiological consequences of fining tuning CaV1.3 channels by RNA 
editing. The second part of the thesis examines tissue specific alternative splicing of 
CaV1.3 channels. Splicing patterns in several hotspots including IS5-IS6, I-II loop and 
IVS3-IVS4 were investigated in both rat brain and heart tissues. Functional 
characterization of dominant splice isoforms revealed that alternative splicing in the 
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IS5-IS6 region and I-II loop significantly altered the activation property of the 
channel while that in the IVS3-IVS4 region modulated the sensitivity of the channel 













































2.1 Background and objectives 
Calcium dependent inactivation represents an important feedback mechanism 
that controls calcium influx through CaV1 and CaV2 channels and therefore impacts 
downstream chemical and electrical signaling in excitable cells. A cartoon of CaV1.3 
highlights the molecular elements crucial for Ca2+/CaM -mediated CDI which serves 
as a structural context for the screening of RNA editing (Figure 2.1A). The presence 
of N-terminal spatial Ca2+ transforming element (NSCaTE) domain at the N-terminus 
of CaV1.3 channels binds to Ca2+/N-lobe of CaM and localizes the sensitivity of 
N-lobe regulated CDI around the pore region (Dick et al., 2008; Tadross et al., 2008). 
In the C-terminus, EF hand domain supports the transduction of Ca2+-CaM binding 
into channel inactivation (de Leon et al., 1995; Peterson et al., 2000; Kim et al., 2004). 
Distal to the EF hand, the PreIQ-IQ domain anchors Ca2+/C-lobe of calmodulin (Van 
Petegem et al., 2005) and specifically, the IQ domain functions as the effector site for 
Ca2+/C-lobe regulated CDI of L-type channels as revealed by numerous mutational 
studies (Erickson et al., 2003; Liang et al., 2003; Kim et al., 2004).  
Although both lobes of calmodulin are able to mediate CDI independently, 
C-lobe regulation is dominant in CaV1.3 channels, as close to 90% of CDI was 
eliminated upon co-expression with a mutant calmodulin with Ca2+ insensitive C-lobe 
(Yang et al., 2006). The remaining 10% of CDI which is attributed to N-lobe 
regulation is eliminated upon mutation in NSCaTE domain (Yang et al., 2006; Dick et 
al., 2008), suggesting independence in these two modes of regulation via distinct 
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action sites. Though collective actions of these different structural domains shape CDI 
profile of the CaV1.3 channels, single mutations at some of these hotspots could 
significantly affect CDI (Peterson et al., 2000; Zuhlke et al., 2000; Dick et al., 2008; 
Tadross et al., 2008; Liu et al., 2010). Nowhere is this single-residue alteration of CDI 
better known than in the IQ domain (Dunlap, 2007), approximating a consensus 
sequence of IQxxxRGxxxR. Interestingly, our initial screening of α1D transcripts from 
rat brain and spinal cord revealed selective editing in IQ domain. Given the important 
role of IQ domain in supporting Ca2+/C-lobe mediated CDI, we therefore hypothesize 
that amino acid alteration due to editing could modify CDI profile of CaV1.3 channels 
which then possibly impacts the physiological functions of CaV1.3 channels such as 
neuronal pacemaking.  
Here we aim to understand both the mechanism and the functional effects of RNA 
editing in the CaV1.3 IQ domain. Firstly, we sought to profile the editing level of α1D 
transcripts in mammalian tissues where the channels are abundantly expressed. 
Secondly, we strived to understand the RNA structure behind IQ domain editing. 
Thirdly, we aimed to understand the functional impacts of IQ domain editing on the 
expression and electrophysiological properties of CaV1.3 channels in heterologous 
expression system. Fourthly, we examined the effect of editing on suprachiasmatic 
nucleus pacemaking which is underpinned by CaV1.3 current. 
2.2 Materials and methods 
Tissue preparation and total RNA extraction   
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Experiments were carried out on adult Sprague-Dawley rats and C57BL mice, as 
approved by the institutional IACUC. Brain and spinal cord were dissected for 
RT-PCR experiments. Total RNA was isolated using the Trizol method (Invitrogen, 
Carlsbad, CA) and first strand cDNA was synthesized with Superscript II and 
oligo(dT)18 primers (Invitrogen, Carlsbad, CA). Negative control reactions without 
reverse transcriptase were performed in all reverse transcription RT-PCR experiments 
to exclude contamination by genomic DNA.  Reverse transcription to generate the 
first strand cDNA was performed by standard methods. 
Transcripts scanning for edited sites.   
For rat, transcript-scanning of the CaV1.3 IQ domain was done by using the primer 
pairs  
sense primer: 5’-GAGCTCCGCGCTGTGATAAAGAAA-3’;  
and antisense primer: 5’-GGTTTGGAGTCTTCTGGTTCGTCA-3’  
 to amplify a 300 bp CaV1.3 fragment.    
For mouse, the primer pairs used were  
sense primer: 5’-CTCCGAGCTGTGATCAAGAAAATCTGG-3’;  
and antisense primer: 5’-GGTTTGGAGTCTTCTGGCTCGTCA-3’ 
 for a 299 bp amplicon.  
For human, the primer pairs used were  
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sense primer: 5’-CTTTGGTTCGAACGGCTCTTA-3’;  
and antisense primer: 5’-TGTAGGGCAATTGTGGTGTTCT-3’ 
 for a 268 bp amplicon.  
A standard step-down PCR protocol was used that included a 5-cycle decrement from 
59 °C to 53 oC final annealing temperature. The number of cycles for the main PCR 
was 30, where denaturation was performed at 94 oC for 30 sec, annealing at 53 oC for 
30 sec, and extension at 72 oC for 50 sec.  The final extension was at 72 oC for 5 min. 
PCR products were separated on a 1% agarose gel, isolated and purified using the 
Qiagen gel extraction kit.  The PCR product was sent for direct automated DNA 
sequencing (Applied Biosystems, Foster City, CA).  Colony screening was 
performed by first sub-cloning PCR products into pGEM-T Easy vector (Promega, 
Madison, WI), transforming them into DH10B Escherichia coli cells, and then 
sending ~50 isolated clones for automated DNA sequencing. Three rats or mice were 
used for each group of animals. A total of 150 clones were screened to determine 
RNA editing for each brain or spinal cord region. To compare peak heights of the 
chromatogram bases, the peak height of guanosine was divided by the combined peak 
heights of adenosine and guanosine bases to estimate the percent of RNA editing. For 
human, transcripts scanning were performed using commercial cDNA libraries 
(Clonetech, USA), including Human brain whole QUICK-Clone  cDNA Cat# 
637242, Human brain amygdala QUICK-Clone cDNA Cat# 637244, Human brain 
cerebellum QUICK-Clone  cDNA Cat# 637212, Human Brain hypothalamus 
  26
Marathon-Ready cDNA Cat# 639329, Human Brain substantia nigra QUICK-Clone 
cDNA Cat#  637245, Human Heart QUICK-Clone Cat# 637213, Human Pancreas 
QUICK-Clone cDNA Cat# 637207, Human Retina QUICK-Clone cDNA Cat# 
637216. 
Construction of rat short-form and long-form CaV1.3 with edited IQ domain   
The first four amino acids of the CaV1.3 consensus IQ domain is IQDY are coded by 
nucleotide sequence ATACAGGACTAC. Total six edited CaV1.3 α1D-SF subunits were 
generated from the reference wildtype α1D-SF channels (Xu and Lipscombe, 2001); 
GenBank accession number AF370009.1), now designated SF-IQDY. The six edited 
CaV1.3 α1D-SF subunits were named SF-MQDY, SF-IRDY, SF-MRDY, SF-IQDY, 
SF-IQDC, SF-MQDC, SF-MRDC. On the other hand, three edited CaV1.3 α1D-LF 
subunits were generated from CaV1.3LF A2123V, also named as LF-IQDY.  The CaV1.3 
α1D-L subunits were named LF-MQDY, LF-IQDC and LF-MQDC. 
The α1D-SF edited clones were generated by replacing a BstEII/NotI RT-PCR fragment 
containing the respective edited sites into the reference α1D-SF construct while the 
edited CaV1.3 α1D-LF subunits were generated by replacing a BSTEII/KpnI RT-PCR 
fragment containing the respective edited site into the reference CaV1.3LF A2123V 
construct.  
The CaV1.3LF A2123V construct first was generated from CaV1.3 α1D construct (Xu et al., 
2001; GenBank accession number AF370010.1) by mutating alanine2123 to valine. The 
CaV1.3LF A2123V construct was generated by Miss Tan Bao Zhen.  
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Construction of minigene construct and mutagenesis  
The minigene construct pRK5-gIQECS was generated by ligating a SpeI/XhoI 
genomic DNA fragment digested from mouse bacterial artificial chromosome 
(Library Plates 481, ResGen, USA, CA) into pRK5 vector digested by XbaI/SalI 
(Higuchi et al., 1993). The genomic DNA fragment of size of 4952bp, contains the 
putative ECS, intermediate sequence and exon 41. To generate pRK5-gIQΔECS 
construct, two DNA fragments immediately upstream and downstream of ECS were 
amplified by PCR with the following primers   
ECS upstream forward: 5’- AAGGATCCTCTAGTCTCCGGTC-3’;  
ECS upstream reverse: 5’- GTGGAAGCTGCAGAGGAAGCTC-3’ 
 and  
ECS downstream forward: 5’- CAGAGTTATCTCTTGCCAACTGGA-3’;  
ECS downstream reverse: 5’- TTCGAACCACCCATCTGTCCCAA-3’ 
 Subsequently, the two PCR fragments were joined by overlapping PCR with the 
primers  
ECS overlap forward: 5’- CTCTGCAGCTTCCACCAGAGTTATCTCTTG-3’;  
ECS overlap reverse: 5’- CAAGAGATAACTCTGGTGGAAGCTGCAGAG-3’ 
before being ligated back into pRK5-gIQECS by digestion with BamHI and BstEII.  
To generate M1, M2 and M3 construct, a 1774bp fragment spanning ECS was used a 
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template for site directed mutagenesis (QuickChange II Xl site-directed mutagenesis 
kit, Stratagene) employing the following set of primers respectively 
M1 forward: 5’- TCTGAAGCAATTCTGaTTTAGGGTGGTGGCA-3’;  
M1 reverse: 5’- TGCCACCACCCTAAAtCAGAATTGCTTCAGA-3’ 
M2 forward: 5’- ATTCTGAAGCAATTCaGTTTTAGGGTGGTGG-3’;  
M2 reverse: 5’- CCACCACCCTAAAACtGAATTGCTTCAGAAT-3’ 
M3  forward: 5’- CAGAATATTCTGAAGTAATTCTGTTTTAGGGT-3’;  
M3 reverse: 5’- ACCCTAAAACAGAATTACTTCAGAATATTCTG-3’ 
Transfection of HEK293 cell and assay for editing level 
HEK cell cultured in DMEM with 10% (v/v) FBS were co-transfected with 0.1 ug of 
minigene reporters pRK5-gIQECS, pRK5-gIQΔECS, mutated construct M1, M2 and 
M2 with different amount of pIRES2-AcGFP1-ADAR2 by calcium phosphate method 
(Tang et al., 2004). The rat ADAR2 expression vector was kindly provided by Dr. 
Miyoko Higuchi, Max Planck Institute of Biomedical Research and subsequently 
cloned into pIRES2-AcGFP1 to allow for monitoring the expression efficiency. For 
measuring the editing efficiency with different amount of ADAR2, different amounts 
of empty pIRES2-AcGFP1 vector was included in the transfection so that the total 
amount of pIRES2-AcGFP1-ADAR2 and pIRES2-AcGFP1 was always 2 μg. The 
expression efficiency usually averaged from 30 to 50% was monitored by visual 
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counting of around 100 random cells.  
The transfected HEK293 cells were harvested 48 hours after transfection and total 
RNA was prepared with Trizol method. The RNA samples were treated with 
RNase-free DNase (Ambion) before reverse transcription using the reverse primer 5’- 
GCGGTACCAATAAACAAGTTGGGCCATGG-3’. Subsequent PCR was performed 
with the primers pair 
sense primer: 5’-GGTGGCGCTTCCTATCGTTA-3’;  
and antisense primer: 5’-AGGGGCAGTGGGCAGTATCTC-3’  
 for a 560 bp amplicon. The efficiency of editing was assessed by DNA sequencing 
with either the sense or antisense primer.  
Construction of wildtype and edited rat short-form CaV1.3 with hemagglutinin (HA) 
tag 
The construction of HA-tagged CaV1.2 has been described by Altier et al., 2002. 
Briefly, the HA tag was first generated by klenow filling with two partially 
complementary oligos including  
HA oligo forward:  
5’-CGGAGGGAAGTTCAATTTCGATGAGACACAGACTCGTCATTATCCTTATG
ATGTTCCTGATTATGCTGTTACTTTTGATG -3’; 




Subsequently the HA oligo was joined to two DNA fragments upstream and 
downstream of the point of insertion of HA tag by overlapping PCR before being 
ligated back to the short-form CaV1.3 expression vector by double digestion with AleI 
and AfeI. The amino acid sequence at the HA epitope insertion site reads 
690DETQTRHYPYDVPDYAVTFDEMQTKRS716. Subsequently different edited 
isoforms with HA tag were generated by replacing a BstEII/NotI RT-PCR fragment 
containing the respective edited sites into the reference construct HA-CaV1.3SF. 
Immunocytochemistry and confocal imaging  
The experiment was performed by Miss Tan Bao Zhen as a collaborative effect. 
Briefly, 48 hours after transfection, neurons were fixed using paraformaldehyde, 
washed thrice, and blocked using BSA. Anti-CaV1.3 antibody (ACC-005, Alomone) 
and HA antibody (12CA5, Roche) was applied overnight at 4 °C. Neurons were 
washed and stained with secondary anti-mouse antibody coupled with Alexa Fluor 
498 (green) and Alexa Fluor 594 (red) for 1 h at room temperature. Coverslips were 
washed thrice and mounted for visualization. Images were acquired using a Zeiss 
LSM-510 META confocal microscope using a 63 1.4NA oil immersion objective in 
the inverted configuration. 
 
Patch-clamp electrophysiology  
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For recording of recombinant CaV1.3 channels during heterologous expression in 
HEK293 cells, IBa or ICa was recorded at room temperature using the whole-cell patch 
clamp electrophysiological technique, 48-72 h after transfection. The external solution 
used contained 10 mM HEPES, 140 mM tetraethylammonium methanesulfonate, 5 
mM BaCl2 or CaCl2 (pH was adjusted to 7.4 with CsOH and osmolarity to 290-310 
mosM with glucose). The internal solution (pipette solution) contained 130 mM 
Cs-MeSO3, 5 mM CsCl, 5 mM EGTA, 10 mM HEPES, 1 mM MgCl2, 2 mg/ml 
Mg-ATP, pH 7.3 (adjusted with CsOH). The osmolarities of solutions used were 
adjusted to between 290 and 300 mosM with glucose. In our recording condition, the 
reported voltages are uncorrected for a -11 mV junction potential, and true voltage 
may be obtained by subtracting 11 mV from the reported values. Whole-cell currents, 
obtained under voltage clamp with a Multiclamp 700 amplifier equipped with 
pCLAMP 9.2 software (Molecular Devices, USA), were filtered at 1-5 kHz and 
sampled at 5-50 kHz.  Pipettes of resistance 1.5-2 M were used. The series 
resistance was typically < 5 M, before compensation by > 70%. The P/4 protocol 
was used to subtract online the leak and capacitive transients.  
Stepwise whole cell currents (Figure 2.8, Figure 2.10, first, second and bottom panel, 
Figure 2.9) were obtained with Ba2+ or Ca2+ as charge carrier. Currents were recorded 
by holding the cell at -90 mV, before stepping to various potentials from -60 mV to 50 
mV for 1 s.  In each cell, peak currents at all voltages were normalized to the largest 
current observed (usually at -10 or -20 mV).  Recovery (Figure 2.8, Figure 2.10, 
third panel) was investigated using a standard two-pulse protocol (Liao et al., 2007). 
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Briefly, following a 2 s depolarizing pre-pulse to Vmax (determined from I-V properties 
of the transfected cell), a test-pulse is applied after a certain time period, ΔT, has 
elapsed. 
Data Analysis   
Data were analyzed by using Microsoft Excel and GraphPad Prism IV software (San 
Diego, CA), and were displayed as mean values ± SEM.  Statistical significance of 
differences between means was calculated with two-tail, unpaired Student’s T-test as 
appropriate (red-shaded differences in main text Figure 2.8 and Figure 2.10 
significant at p < 0.05 level). Calcium dependent inactivation data (Figure 2.8, Figure 
2.10, second panel) were fitted by eye.  Recovery curves and current-voltage 
relationships were analyzed by the following equations, with parameters determined 
using least squares criteria.  
Fractional recovery of peak ICa was plotted against Δt.  Recovery from inactivation 
were fit from the tri-exponential equation:  
Y  = Af  ( 1 – exp (-Δt /τf) ) + Am  ( 1 – exp (-Δt /τm) ) + As  ( 1 – exp (-Δt /τs) ) + 
Ymin  
where Y is the normalized fraction of recovery; Ymin, Af, Am, and As are amplitudes of 
ultra-rapid, fast, medium, and slow recovery components, respectively (these must 
sum to unity); and τf, τm, τs are the recovery time constants for fast, medium, and slow 
components, respectively.  
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  The normalized I-V curves (Figure 2.8, Figure 2.10, bottom panel) were fitted by 
Inorm= Gnorm  GBa  (V- V1/2-GHK) / ( 1 - exp( (V- V1/2-GHK)/ kGHK) ) 
where Gnorm is dual Boltzmann function as described above, for data with Ba2+ as the 
charge carrier.  GBa is an apparent maximum conductance (for normalized currents), 
and V1/2-GHK and kGHK are standard parameters for a GHK current equation.   
SCN slice preparation  
C57BL/6 wildtype (ADAR2+/+/GluR-BR/R) or knockout (ADAR2-/-/GluR-BR/R) mice 
(Higuchi et al., 2000) were maintained on a 12 hr light dark cycle using normal 
fluorescent room light. Coronal brain slices (250 μm thick) containing 
suprachiasmatic nucleus were obtained from 5 to 8 week-old mice anesthetized with 
isoflurane and decapitated. All experimental procedures were in accordance with the 
animal welfare guidelines of the Max-Planck-Society and approved by the IACUC of 
the National University of Singapore. The slicing chamber contained an oxygenated 
ice-cold solution composed of (in mM): NaCl, 125; KCl, 2.5; NaH2PO4, 1.25; 
NaHCO3, 25; MgCl2.6H2O, 1.0; myo-Inositol, 3;  Na-pyruvate, 2; vitamin C, 0.4; 
CaCl2, 1; MgCl2, 5; and glucose, 25. Slices were incubated for 30 min at 30 oC before 
being stored at room temperature in artificial CSF (ACSF) containing (in mM): NaCl, 
125; NaHCO3, 25; KCl, 2.5; NaH2PO4, 1.25; MgCl2, 1; CaCl2, 2; and glucose, 25; 
bubbled with 95% O2 and 5% CO2.  
Whole-cell recording in SCN slices  
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Current-clamp recording were made using EPC-9 amplifier controlled by Patchmaster 
(Heka Elektronik, Lambrecht, Germany). Patch pipettes were pulled from borosilicate 
glass capillaries and had resistances of 4–6 MΩ when filled with (in mM): 
K-gluconate, 130; K-Cl, 10.00; EGTA, 5; N-(2-hydroxyethyl) piperazine- 
N’-ethanesulfonic acid (HEPES); Na3GTP, 0.5; MgATP, 4.0; and Na-Phosphocreatine, 
10.0. Brain slices were mounted on upright fixed stage microscope equipped with 
40X water immersion lens and constantly perfused with the above mentioned 
oxygenated ACSF at a flow rate of 1.5 to 2 ml/min at room temperature. The SCN 
was identified as a bilaterally symmetrical, cell dense region superior to the optic 
chiasm and lateral to the inferior apex of the third ventricle (Pennartz et al., 1998). 
Individual SCN neurons were identified by IR-DIC camera. Only cells in the dorsal 
medial shell were patched where cluster I SCN neurons are dominant (Paxinos and 
Franklin, 2001). The cluster I neurons were identified by their steeply rising and 
monophasic AHP (Pennartz et al., 1998). After formation of gigaseal (>3 GΩ) 
formation, input resistance was monitored regularly by measuring voltage response by 
a -20 pA current injection. The reported membrane potential was corrected for the 
liquid junction potential -14.5 mV. 
Drug Preparation  
Stock solutions were prepared by dissolving nimodipine (RBI) in 100% ethanol, TTX 
(Alomone Labs) and kainate acid in distilled water. The solutions were subsequently 
diluted in external to respective final concentrations. Nimodipine was protected from 
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light during these procedures.  
 
2.3 Results 
Detection of A-to-I RNA editing in the IQ domain of CaV1.3 
At the genomic level, the predicted amino-acid sequence at the core of the IQ 
domain is IQDY. These are coded by the nucleotides ATACAGGACTAC, as explicitly 
confirmed by PCR amplification and sequencing of the rat genomic DNA extracted 
from rat lumbar tissue (Figure 2.1B). However direct sequencing of RT-PCR product  
from rat whole brain and spinal cord lumbar section showed obvious evidence of 
RNA sequence variability at two adenosine positions, characterized by conspicuous 
A/G double peaks in sequencing chromatograms (Figure 2.1C, arrows on green and 
gray bands), suggestive of A-to-I RNA editing. These double peaks indicated that in 
addition to the genomic coded IQDY sequence, alternative sequences like MQDY 
(ATGCAGGACTAC), IQDC (ATACAGGACTGC), and MQDC 
(ATGCAGGACTGC) could also be manifest at the protein level. In addition, visual 
inspection detects higher editing level in both codons in rat brain as compared to 
lumbar section (Figure 2.1C).  
In contrast to the ready detection of RNA sequence variability within the 
CaV1.3 IQ domain, further regions of editing were not observed. Transcript-scanning 
of the complete α1D subunit from total rat brain RNA, using direct sequencing of 
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RT-PCR products, gave no indication of sequence variability outside of the IQ domain 
(data no shown). 
Beyond the CNS, CaV1.3 channels also play important roles in tissues such 
as cochlea, heart, (Platzer et al., 2000; Shen et al., 2006), pancreas (Liu et al., 2004) 
and other tissues. Yet no sequence variability in the IQ domain was observed in these 
tissues (Figure 2.1D) indicating that RNA editing in CaV1.3 was CNS-specific.  
Subsequently, colony screening was performed whereby the RT-PCR 
products from rat brain were sub-cloned into pGEM-T Easy vector, transformed into 
bacterial colonies and sequencing was then performed on amplified PCR products 
from individual colonies. Interestingly, this approach not only confirmed the two sites 
of variability observed above but also revealed a rarer site where CAG (Q) was 
modified to CGG (R) giving arise to total six different combinatorial variations of IQ 
domain (Figure 2.2A) in addition to the WT IQDY. Furthermore, analysis of total 
brain RNA for the paralogous IQ domains of other CaV channels (CaV1.2, CaV1.4, 
CaV2.1, CaV2.2 and CaV2.3) also failed to reveal such variation in respective IQ 
domain (Figure 2.2B). 
In addition we wondered if editing could be detected in other mammalian 
species. Direct sequencing of PCR product amplified from different human cDNA 
libraries of various brain tissues revealed similar editing in the IQ domain (Figure 
2.3A). However surprisingly in human, significant A/G double peaks were observed 
only at the ATA codon but not in the TAC codon as compared to rat, indicating species 
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specific specialization of IQ domain editing. Consistently, RNA editing is absent in 
peripheral tissues including heart, pancreas and retina (Figure 2.3B) confirming that 
tissue specific editing of the IQ domain is evolutionarily conserved.  
 
 
Figure 2.1 Detecting RNA editing in the rat CaV1.3 IQ domain. A. Cartoon of CaV1.3 
pore-forming 1 subunit (α1D), with hotspots for CaM/channel regulation shown on the amino 
terminus (NSCaTE (Dick et al., 2008)), in the carboxyl terminus (EF, EF-hand (Peterson et al., 
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2000); preIQ and IQ domains (Pitt et al., 2001; Erickson et al., 2003) and lastly the ICDI domain 
(Singh et al., 2008; Liu et al., 2010). B. DNA sequencing chromatogram from direct analysis of 
PCR of rat genomic DNA yielding unique coding for IQ domain at this level. C. Direct sequencing 
results of RT-PCR from rat whole brain (top) and spinal cord lumbar (bottom), showing distinct 
doublets of adenosine (A) and guanosine (G) as indicated by the arrows. D. Direct sequencing 
results for RT-PCR of cochlea, heart, DRG and pancreatic -islets, showing identical patterns to 




Figure 2.2 Examples of CaV1.3 IQ-domain RNA editing within individual clones, and absence of 
IQ-domain editing in other CaV channel isoforms. A. Sampling of possible combinations CaV1.3 
IQ domain editing in rat brain, as evidenced by DNA sequences from individual clones. These 
chromatograms show editing at 2-3 sites in various combinations. B. RNA editing was not 
detected in the IQ domains of other voltage-gated calcium channels (CaV2.1, CaV2.2, CaV2.3, 
CaV1.2, and CaV1.4 channels). Direct sequencing of RT-PCR products from rat brain did not show 
















Figure 2.3 Detecting RNA editing in the human CaV1.3 IQ domain. A. Direct sequencing of PCR 
products amplified from various human brain cDNA libraries showing distinct doublets of 
adenosine (A) and guanosine (G) in the first codon ATA as indicated by the arrows. B. Direct 
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sequencing results for PCR products from cDNA libraries of several peripheral tissues including 




ADAR2 mediates editing of the CaV1.3 IQ domain 
The family of ADARs consists of three members including ADAR1, ADAR2 
and ADAR3. While ADAR1 and ADAR2 are expressed ubiquitously and have 
overlapping specificity, ADAR3 expresses only in the brain and has no known 
substrates (Melcher et al., 1996).  
To test whether the specific isoform ADAR2 is responsible for the CaV1.3 
IQ-domain editing, we screened for IQ domain editing in both wildtype 
(ADAR2+/+/GluR-BR/R) and ADAR knockout (ADAR2-/-/GluR-BR/R) mice (Higuchi et 
al., 2000), focusing particularly upon the spinal cord lumbar and whole-brain regions. 
Direct DNA sequencing of RT-PCR products from these regions in wildtype mice 
gave strong qualitative indications of sequence variability (Figure 2.4 B, left) at each 
of the locations identified earlier in rat brain and spinal lumbar regions (Figure 2.1C).  
The level of editing at each site was quantified by the ratio of the peak height for 
adenosine over the sum of heights for adenosine and guanosine. The results were 
depicted as light-colored bar graphs (Figure 2.4B, right). Reassuringly, measurement 
of chromatogram areas yielded identical estimates of level of editing (Figure 2.4E). 
Additionally, as an independent measure of editing level, the RT-PCR products were 
cloned into bacterial colonies and screening of around 50 cDNA clones by DNA 
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sequencing produced a closely similar quantitative profile of sequence variability at 
each of the editing site (Figure 2.4B, right, darker-colored bars). The quantitative 
analyses revealed an overall rank order of editing efficiency (most frequent to rarest) 
of: ATA (I) recoding to ATG (M), followed at a slightly lower frequency by TAC (Y) 
recoding to TGC (C), followed much more rarely by CAG (Q) recoding to CGG (R). 
The extensive colony analysis revealed overall tissue specific frequency distribution 
of IQ-domain sequence combinations as reported in Figure 2.4D. Given this rich 
assortment of variants in wild-type mice, similar experiments were performed 
regarding the origin of this variability. Indeed, no editing was observed in the ADAR2 
knockout mice (Figure 2.4C), thus arguing strongly that ADAR2 is necessary for 
CaV1.3 IQ-domain editing.  
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Figure 2.4 RNA editing of CaV1.3 IQ domain regulated by ADAR2. A. Schematic of mechanism 
of editing mediated by ADAR2. Transcription of pre-mRNA with formation of putative ECS 
duplex (top); recruitment of ADAR2 to duplex (second from top); conversion of adenosine to 
inosine (third from top); edited mature transcript ready for exportation to cytoplasm and 
translation (bottom). B. Profile of editing in mouse lumbar and whole brain. Left column, direct 
DNA sequencing of mouse RT-PCR products. Right column, percent editing at three locations 
(I-to-M, Q-to-R and Y-to-C), as calculated by measuring electropherograms heights for adenosine 
versus guanosine (translucent bars), or by colony counting from colony screening analysis (filled 
bars). C. No editing in ADAR2-/-/GluR-BR/R knockout mice. Format as in panel B. D. Top panel, 
overall frequency distribution of CaV1.3 IQ-domain variants, taken from mouse wildtype (WT) 
whole-brain via colony counting method. IRDC combination was never observed. Bottom, overall 
frequency distribution observed in WT lumbar region. E.  Equivalence of peak-height and area 
metrics for RNA editing, based on sequencing chromatography.  Symbols represent editing 
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percentages calculated via peak heights of sequencing chromatograms, plotted as a function of 
editing percentages calculated via area under sequencing chromatograms, performed for data sets 
in panel B. Open circles, lumbar; filled circles; whole brain; solid line, line of identity. 
Double stranded RNA structure underlying the IQ domain editing 
ADAR2 works by recognizing double stranded RNA structure that is usually 
formed between the edited site and a flanking intronic sequence known as editing site 
complementary sequence (ECS). Such RNA duplex structures have been consistently 
observed in all ADAR2 substrates identified so far (Higuchi et al., 1993; Burns et al., 
1997; Bhalla et al., 2004; Dawson et al., 2004; Ohlson et al., 2007). Despite the 
abundance of secondary RNA structures, only a limited number of RNAs are 
selectively edited by ARAR2 as governed by factors such as length requirement 
(Macbeth et al., 2004), structure of the RNA duplex (Lehmann and Bass, 1999) and 
even nucleotide sequence bias surrounding the edited site (Dawson et al., 2004; Stefl 
et al., 2010), in contrast to the conventional belief that ADAR2 lack sequence 
specificity. Identifying similar RNA duplex structure in CaV1.3 would not only 
validate IQ-domain editing but would also shed light on how its editing is specifically 
regulated. 
To achieve such a goal, mouse genomic DNA sequence including exon 41 
that codes for IQ domain and various lengths of upstream and/or downstream flanking 
introns was modeled by Mfold webserver 
(http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi). The result indicated that an 
imperfect double stranded RNA structure of around 40 base pair could be formed 
between the exon 41 and an intronic sequence located in intron 40, around 3700 nt 
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upstream of exon 41 (Figure 2.5A). The 40-base pair (bp) secondary structure was 
disrupted by four bulges. Whereas the edited adenosine nucleotide for the ATA and 
CAG lie in the stem structure between the second and third bulges from the left, the 
adenosine of the TAC codon is located in the second bulge (Figure 2.5A). It is known 
that 50% of adenosine in a perfect RNA duplex could be randomly edited by ADAR1 
and ADAR2 in vitro, while the presence of bulge and loop structure in the RNA 
duplex possibly directs editing in selective position (Lehmann and Bass, 1999).  
In order to experimentally validate the identified ECS, a minigene construct 
named as pRK5-gIQECS was generated by sub-cloning a 4952 bp long mouse 
genomic sequence spanning the putative ECS, intermediate intronic sequence and 
exon 41 into pRK5 expression vector. Subsequently another construct 
pRK5-gIQΔECS was made by deleting the ECS in the same construct (Figure 2.5B). 
Transient co-transfection of pRK5-gIQECS with ADAR2 yielded robust editing in 
codon ATA and TAC. With intact ECS, both codons was edited at similar efficiency 
and the level of editing increased with increasing amount of ADAR2 co-transfected, 
reaching around 60% with 0.25 μg of ADAR2 and saturating at around 80% with 1μg 
of ADAR2, though further increase of ADAR2 resulted in slight decrease in the 
editing level (Figure 2.5C). No significant editing in CAG was observed in all 
transfections (Figure 2.5C). Significantly, deletion of ECS completely eliminated 
editing in both ATA and TAC codons, highlighting the importance of double stranded 




Figure 2.5 Identification of editing site complementary sequence (ECS) that facilitates the editing 
at the IQ domain of CaV1.3 channels. A. RNA duplex structure predicted by mfold webserver 
(http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi) is formed between the edited site and an 
intronic sequence 3700 nt upstream of exon 41. Mouse genomic sequence (Genbank assess no. 
NT_039606.7) was modeled. The edited adenosine was highlighted in red and arrows indicate 
respective amino acid changes. B. Schematic diagram indicates the mouse genomic fragment used 
for editing analysis. Top, the open boxes indicate the position of Exon 41. The fill box indicates 
the position of ECS and the edited sites in the IQ domain are highlighted by the star and lines 
represent the intronic sequence. Bottom, in the same construct, the ECS sequence was 
subsequently deleted. C. 0.1 ug of pRK5-gIQECS or pRK5-gIQΔECS were co-transfected with 
different amount of pIRES2-AcGFP1-ADAR2 in HEK293 cell respectively. The level of editing 
was plotted against ratio of amount of ADAR2 transfected. Robust editing was observed in the 
codon ATA and TAC upon co-transfection of pRK5-gIQECS with ADAR2 (mean ± SEM., n=3). 
Deletion of ECS in pRK5-gIQΔECS completely eliminated editing in these two codons. No 
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significant editing in the CAG codon in all transfection and editing were no observed when either 
pRK5-gIQECS or pRK5-gIQΔECS was co-expressed with ADAR2 (data no shown). 
 
Single nucleotide mutations in the ECS disrupt editing at specific site 
To rule out the possibility that effect of deletion of ECS was due to 
non-specific disruption of folding of RNA structure and to further test the 
computer-predicted base pair interaction in the RNA duplex, single nucleotide 
mutations were engineered at the ECS sequence. The base pairing at the edited 
adenosine residue of ATA and CAG codon were disrupted by mutating the base paired 
thymidine residue to adenosine residue in the M1 and M2 construct respectively while 
the base pairing at the adenosine residue of TAC codon was restored by mutating 
cytosine to thymine in the M3 construct (Figure 2.6B). Taking advantage of the cell 
culture assay, mutant constructs harboring different mutations were co-transfected 
with pIRES2-AcGFP1-ADAR2 in HEK293 cell. Direct sequencing of the RT-PCR 
products revealed that M1 mutation reduced the editing efficiency at the ATA and 
TAC codon by around 40% (p < 0.001, n =4) and 16% (p < 0.05, n =4) respectively 
(Figure 2.6C). M2 mutation reduced the editing at both codons by 20% (p < 0.05, n 
=4) and 28% (p < 0.01, n =4) respectively (Figure 2.6C). M3 mutation was found to 
specifically reduce editing of TAC codon by 37% (p < 0.01, n =3) while leave the 
editing in ATA intact (Figure 2.6C). The results conclusively verified the base-pairing 
interaction between ECS and the IQ domain and indicated that correct RNA folding at 




Figure 2.6 Disruption of editing in the IQ domain by single nucleotide mutations in the ECS. A. 
The predicted RNA duplex structure formed between ECS and edited site reproduced from Fig. 
2.5A. B. DNA mutations engineered into expression vector M1, M2 and M3 were designed to 
specifically disrupt (M1 and M2) or restore (M3) single base pairing. The mutated nucleotides in 
the ECS were highlighted in green. C. Bar chart summarizes the level of editing of at ATA and 
TAC upon transient co-transfection in HEK293 with 0.1 ug of either WT or mutant minigene 
constructs and 0.5 ug of pIRES2-AcGFP1-ADAR2 (mean ± SEM., n=3). All values were 
normalized to the percentage of editing observed for WT minigene at position ATA (0.71 ± 0.04%) 
and TAC (0.68 ± 0.02%). 
 
Evolutionary conservation of mechanism in the IQ domain editing 
As IQ-domain editing was observed in all mammalian species screened so far 
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including rat, human and mouse, we wondered if the RNA duplex structure observed 
in mouse could also be conserved across different species. Human and rat genomic 
sequence spanning ECS detected in mouse, intermediate sequence and edited exon 41 
were similarly modeled by Mfold webserver. Reassuringly, the same structure in 
mouse were also found in human and rat (Figure 2.7A to C) and subsequent sequence 
alignment revealed almost identical sequence in the ECS and IQ exon (Figure 2.7D).  
The result thus suggests that rather than a species convergence event, the IQ domain 





Figure 2.7 Evolutionary conservation of RNA duplex structures and DNA sequences of intronic 
ECS and IQ exon. A. RNA duplex structure predicted by Mfold reproduced from Fig. 2.5A. B. 
Mfold predicted RNA duplex structure detected in human. Human genomic sequence (Genbank 
assess no. NW_921651.1) was modeled. C. Mfold predicted RNA duplex structure detected in rat. 
Rat genomic sequence (Genbank assess no. NW_001084711) was modeled. D. Sequence 
alignment showing high degree of sequence conservation in the ECS sequence and edited exon 41. 
The sequence for mouse, human and rat shown in blue, black and purple respectively while edited 
adenosine shown in red. Sequence differences highlighted in green. 
 
Modulation of CDI by RNA editing in rat short-form CaV1.3 channels 
After the discovery of the existence and molecular basis of CaV1.3 
IQ-domain RNA editing, we proceeded to investigate the critical question of its 
functional impact on CaM-mediated CDI of CaV1.3 channels. Prior structure-function 
work on CaV1.3 would suggest that mutation of the critical isoleucine-glutamine (IQ) 
di-peptide residues significantly attenuate this important Ca2+ feedback system (Yang 
et al., 2006). To test if editing in the IQ domain results in similar functional outcome, 
we first performed electrophysiological analysis of recombinant short-form CaV1.3 
channels (Xu and Lipscombe, 2001, Genbank accession no. AF370009.1) bearing the 
different IQ domain variants observed in rat brain (Figure 2.2A).  As a reference, 
Figure 2.8A displays the SF IQDY profile.  Exemplar Ba2+ currents (top panel, black 
trace), as evoked by maintained depolarization to near the peak of I-V relations, 
showed little decay, indicative of minimal voltage-dependent inactivation (VDI).  In 
contrast, exemplar Ca2+ currents evoked at the same potential showed a rapid decay 
(top panel, red trace), as produced by robust CaM-mediated CDI (Yang et al., 2006).  
Inactivation profiles, averaged over many cells, are displayed in the next two panels 
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below.  The fraction of peak Ba2+ current remaining after 50-ms depolarization to 
various potentials (r50) hovers near unity, consistent with little VDI. Again in contrast, 
strong CDI is apparent in the sharp decline of the Ca2+ r50 relation, which exhibited a 
U-shaped voltage dependence characteristic of a genuine Ca2+-driven process. Pure 
CDI was quantified by the f-value, calculated as the difference in r50 measured in Ba2+ 
and Ca2+ at -10 mV. The difference between Ca2+ and Ba2+ relations then specifies 
CDI measured in isolation. The multi-second recovery from CDI is reported in the 
third panel by the fraction of peak current recovered after increasing durations at the 
holding potential (Frecovery). Finally, as for activation, the bottom panel displays the 
normalized peak Ba2+ current versus voltage curve (Inorm, IV).  
CaV1.3 channels bearing the IQ-to-MQ edited isoform of the IQ domain 
demonstrated a clearly weaker CDI (Figure 2.8B, top two panels, SF IQDY: f = 0.72 ± 
0.01; SF MQDY: f = 0.45 ± 0.03), and perhaps a hint of faster recovery from 
inactivation.  Wildtype profiles are reproduced as dashed curves, and the red shading 
emphasizes the effects of editing.  The flat exemplar Ba2+ current and r50 relation 
(Figure 2.8B, top two panels) demonstrated unchanged VDI. V1/2 act (voltage for half 
activation) and Vmax (potential for maximum current) derived from I-V relationship 
were shifted slightly by 2.65 mV and 4.56 mV respectively to the right (Figure 2.8B, 
bottom panel and Table 2.1). Channels with the IQ-to-IR edited isoform of the IQ 
domain exhibited similar though weaker alteration of CDI (Figure 2.8C, f = 0.60 ± 
0.01), and closely similar recovery from inactivation as control while activation 
property was not significantly affected (Figure 2.8C, bottom panel and Table 2.1). 
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Most strikingly, the IQ-to-MR edited channels demonstrated pronounced 
effectsapproximately 50% reduction in the onset of CDI (Figure 2.8D, f = 0.33 ± 
0.01), and sharply accelerated recovery from inactivationthat are both highly 
significant. V1/2 act and Vmax for SF MRDY were positively shifted by 1.44 mV and 
5.13 mV respectively (Figure 2.8D, bottom panel and Table 2.1). 
Furthermore Y-to-C editing of the IQ domain had little functional effect on 
CDI as compared to the WT (Figure 2.8E, top two panels), although the early phase of 
recovery appears to be accelerated (Figure 2.8E, third panel). Additional mutation Y 
to C in MQDY and MRDY did not further modify the CDI of their respective edited 
isoforms (Figure 2.8F and 2.8G) except that the enhanced recovery from CDI 
observed in MRDY was almost eliminated upon Y-to-C change. 
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Figure 2.8 Modulation of Ca2+-dependent inactivation by IQ domain editing in SF CaV1.3 background. A. Channel gating properties of short-form wildtype (IQDY).  
Top panel, exemplar traces of currents evoked from holding potential of -90 mV to test potential of -10 mV, with Ba2+ as charge carrier (black), Ca2+ as charge carrier 
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(red).  Throughout, vertical scale bar pertains to Ca2+ current, and Ba2+ currents are scaled down ~3 to facilitate visual assessment of kinetic decay.  Second panel, 
averaged inactivation profiles shown by r50, the fraction of peak currents remaining after 50-ms depolarization to indicated voltages (V).  VDI characterized by Ba2+ 
data; CDI was quantified by a f-value that is the difference of r50-values between Ca2+ and Ba2+ profiles at -10 mV. Third panel, semi-log plot of fractional recovery 
from Ca2+ dependent inactivation. Fourth panel, normalized peak Ba2+ current versus voltage relation. Currents were normalized to maximum values before 
averaging. B. Gating profile for SF MQDY channel variant.  Format as in A.  Slowed CDI onset and enhanced CDI recovery apparent in top three panels, with 
wildtype profiles reproduced as dashed gray curves, and shaded region emphasizing important differences. Activation gating shifted to the right, as shown in bottom 
panel. C. Gating profile for SF IRDY channel variant, showing lesser effects on CDI. Format as in panel B.  D. Gating profile for SF MRDY channel variant, 
showing strongest effects on CDI. Activation gating shifted to the right. Format as in panel B. E. Gating profile for SF IQDC channel variant, CDI unaffected as 
compared to the SF WT. Activation property remained unchanged. Format as in panel B. F. Gating profile for SF MQDC channel variant, CDI not further slowed as 
compared to MQDY while CDI recovery not significantly different from WT. Format as in panel B. G. Gating profile for SF MRDC channel variant, CDI not further 





Table 2.1 Electrophysiological properties of SF WT CaV1.3 channels in comparison 
with different SF edited variants. 
 
Number of experiments is indicated in parentheses. For statistics, a p < 0.01, b p < 0.05 compared 
with CaV1.3SF (Student’s t test, two tails, unpaired).    
 
Neuronal surface expression of α1D remained unaltered by editing 
Previous report suggested a role for the IQ domain in CaV trafficking (Gao et 
al., 2000) due to possibly an ER retention sequence in the C-terminus overlapping 
with IQ domain (Altier et al., 2011). To assess whether editing affects the ability of 
CaV1.3 channels to target to the neuronal surface membrane, an extracellular HA tag 
was engineered into the short-form CaV1.3 channels and different edited channel 
variants including MQDY, MRDY, IRDY and IQDC to facilitate subsequent 
immunocytochemical assays of surface-membrane expression. As a preliminary check, 
electrophysiological characterization of heterologously expressed channels in HEK 
293 cells confirmed the absence of appreciable functional effects of the HA epitope 
itself (Figure 2.9A).  The suite of HA-tagged CaV1.3 clones were then transfected in 
primary hippocampal neurons.  Immunocytochemistry revealed similar surface 
expression patterns between the unedited and edited isoforms of CaV1.3 channels 
IV Construct 
V1/2 act (mV) Vmax (mV) 
f-value at r50 f-value at r300 
SF WT (IQDY) -36.52 ± 0.58 (15) -21.66 ± 0.70 (15) 0.72 ± 0.01 (9) 0.71 ± 0.04 (9) 
SF MQDY -33.87 ± 0.57 (18) a -17.10 ± 0.92 (18) a 0.46 ± 0.03 (18) a 0.51 ± 0.03 (18) a 
SF IRDY -36.01 ± 0.73 (10)  -21.39 ± 0.91 (10) 0.60 ± 0.01 (10) a 0.68 ± 0.02 (10) 
SF MRDY -35.08 ± 0.90 (18)b  -16.53 ± 1.07 (18) a 0.33 ± 0.03 (13) a 0.51 ± 0.03 (13) a 
SF MQDC -36.32 ± 0.69 (7) -20.19 ± 0.74 (7) 0.46 ± 0.03 (7) a 0.57 ± 0.04 (7)b 
SF IQDC -37.91 ± 0.77 (7) -23.77 ± 0.77 (7) 0.70 ± 0.02 (7) 0.74 ± 0.02 (7) 
SF MRDC -35.23 ± 0.55 (11)  -19.23 ± 0.67 (11) a 0.38 ± 0.03 (10) a 0.52 ± 0.02 (10) a 
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(Figure 2.9B), arguing that transport of channels to the neuronal surface membrane 
was largely unaffected by editing.  In addition, expression patterns of transfected 
CaV1.3 were similar to those of endogenous channels (Figure 2.9B). The experiment 
to examine the surface expression of edited channels was a collaborative effort, 
whereby I generated the HA-tagged CaV1.3 channel constructs and characterized them 
eletctrophysiologically while Miss Tan Bao Zhen from the laboratory performed the 




Figure 2.9 Preservation of neuronal surface expression in edited CaV1.3 channels. A.  Inclusion 
of an extracellular HA epitope does not appreciably alter functional expression of wildtype and 
edited CaV1.3 channels. Top, exemplar traces of currents evoked from holding potential of -90 mV 
to test potential of -10 mV, with Ba2+ as charge carrier. Bottom, normalized peak Ba2+ current 
versus voltage relation. Currents were normalized to maximum values before averaging. Symbols 
are averages of 6-8 cells. WT I-V relationship was reproduced as grey dash in second through 
fourth panel. B.  Confocal images of the distribution of the HA-tagged CaV1.3 channels in fixed 
E18 primary hippocampal neurons.  These neurons were transfected with channels bearing 
different versions of the IQ domain. Endogenous and transfected CaV1.3 channels were visualized 
using generic anti-CaV1.3 (green) and anti-HA (red) antibodies, respectively. CaV1.3 without an 
HA epitope was used as negative control. 
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Modulation of CDI by RNA editing in rat long-form CaV1.3 channels 
Although both long-form and short-form CaV1.3 channels are ubiquitously 
expressed in rat brain, as compared to short-form, long-form channels are found to be 
more dominantly expressed and show substantially diminished CDI due to inhibitory 
effect of ICDI domain in the distal tail of the carboxyl terminus (Singh et al., 2008; 
Liu et al., 2010). Subsequently, we wondered whether editing could further modify 
CDI in the long-form backbone. Three long-form dominant edited isoforms revealed 
by transcript scanning were generated bearing MQDY, IQDC and MQDC in the IQ 
domain respectively. Whole-cell electrophysiological analysis of HEK 293 cells 
transiently transfected with CaV1.3LFA2123V revealed the LF IQDY profile in Figure 
2.10A. Exemplar Ba2+ current (top panel, black trace) evoked by depolarization to -10 
mV displayed sharper decay as compared to SF IQDY (Figure 2.10A, top panel) 
indicating faster VDI. In contrast, exemplar Ca2+ currents (top panel, red trace) 
evoked by the same potential display much slower decay as compared to SF CaV1.3 
corroborating with previous finding (Singh et al., 2008). Plotting the Ba2+ r50 against 
various potentials in the next panel revealed faster VDI with gradually increasing 
depolarization while a much shallower U-shaped Ca2+ r50 relation was reflective of 
less effective CaM-mediated CDI. Lastly the pure CDI reported by an f-value 
resembled closely the previous published data (Liu et al., 2010). 
Subsequently, mutating IQ to MQ, as in LF MQDY channel, was shown to 
further attenuate CDI (Figure 2.10B, LF MQDY: f = 0.083 ± 0.002 as compared to LF 
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IQDY: f = 0.19 ± 0.02). Voltage dependent inactivation remained unchanged as 
observed in the overlapping Ba2+ relation between LF MQDY and wildtype (Figure 
2.10B, second panel) while the much shallower Ca2+ relation indicated that IQ-to-MQ 
change selectively affects the CDI. Multi-second recovery from inactivation was not 
significantly changed (Figure 2.10B third panel) Surprisingly, Y-to-C change which 
did not result in any significantly functional alteration in short form CaV1.3, further 
attenuated CDI in long form context (Figure 2.10C, LF IQDC: f = 0.10 ± 0.01). Lastly, 
changing both I to M and Y to C as in LF MQDC did not further slow down CDI as 
compared to either LF MQDY or LF IQDC (Figure 2.10D, LF MQDC: f = 0.10 ± 
0.01). Of interesting note, V1/2 act and Vmax for all three edited long-form isoforms 
were all shifted significantly to more positive potential (Figure 2.10 bottom panel, 
Table 2.2).  
The seeming inconsistency observed between long-form and short-form 
CaV1.3 upon Y-to-C change could probably be resolved by the more recently 
published structure of IQ helix and calmodulin (Van Petegem et al., 2005). The 
tyrosine residue in the IQDY sequence is one of three aromatic anchors that binds to 
the hydrophobic pockets of Ca2+/C-lobe of calmodulin (Van Petegem et al., 2005). In 
CaV1.3SF, the disruption in interaction between IQ domain and Ca2+/C-lobe upon 
Y-to-C change might probably be well compensated by two other hydrophobic 
contacts therefore producing negligible effect on CDI. However the integrity of all 
three hydrophobic contacts becomes essential in the presence of ICDI domain which 
directly competes with calmodulin for binding to the IQ domain. The interaction 
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between IQ and Ca2+/C-lobe will therefore become more sensitive to Y-to-C change 
and further disruption of IQ-Ca2+/C-lobe binding results in even slower CDI as 
observed in long form context.     
 
 
Figure 2.10 Modulation of Ca2+-dependent inactivation by IQ domain editing in LF (long-form) 
CaV1.3 background. A. Channel gating properties of WT (IQDY).  Top panel, exemplar traces of 
currents evoked from holding potential of -90 mV to test potential of -10 mV, with Ba2+ as charge 
carrier (black), Ca2+ as charge carrier (red).  Throughout, vertical scale bar pertains to Ca2+ 
current, and Ba2+ currents are scaled down ~3 to facilitate visual assessment of kinetic decay.  
Second panel, averaged inactivation profiles shown by r50, the fraction of peak currents remaining 
after 50-ms depolarization to indicated voltages (V).  VDI characterized by Ba2+ data; CDI was 
quantified by a f-value that is the difference of r50-values between Ca2+ and Ba2+ profiles at -10 mV. 
Symbols represent the average of 5-8 cells. Third panel, semi-log plot of fractional recovery from 
Ca2+ dependent inactivation. Fourth panel, normalized peak Ba2+ current versus voltage relation. 
Currents were normalized to maximum values before averaging. B. Gating profile for LF MQDY 
channel variant showing slower CDI while recovery not significantly changed. WT profiles 
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reproduced as dashed gray curves, and shaded region emphasizing important differences.  
Activation gating was shifted significantly to the right, as shown in bottom panel. Format as in A.  
C. Gating profile for LF IQDC channel variant, showing slower CDI. Activation gating was 
shifted significantly to the right, as shown in bottom panel. Format as in B.  D. Gating profile for 
LF MQDC channel variant, CDI not further slowed as compared to MQDY.  Activation gating 
was shifted significantly to the right, as shown in bottom panel. Format as in B.   
 
Table 2.2 Electrophysiological properties of LF WT CaV1.3 channels in comparison 
with different LF edited variants. 
 
Number of experiments is indicated in parentheses. For statistics, a p < 0.01, b p < 0.05 compared 
with CaV1.3LF (Student’s t test, two tails, unpaired).    
 
Modification of SCN rhythmicity in ADAR2 knockout mice 
As a first step towards explicitly resolving the biological significance of 
RNA editing of the CaV1.3 IQ domain, we focused on neurons in the suprachiasmatic 
nucleus (SCN), where CaV1.3 current were found to regulate the pacemaking of 
spontaneous action potentials that underlie circadian rhythms (Pennartz et al., 2002). 
Molecular analysis clearly confirmed IQ domain editing in SCN (Figure 2.11A).  
Electrophysiological whole-cell recordings from SCN neurons in acute brain slices of 
wildtype mice (GluR-BR/R) detected the spontaneous discharges of sodium action 
potentials (‘Na spikes’) characteristic of SCN neurons (Figure 2.11B, top black).  In 
contrast, neurons of ADAR2 knockout mice (ADAR2-/- /GluR-BR/R) (Higuchi et al., 
2000) exhibited Na spikes that fired at clearly lower frequencies (Figure 2.11B, 
IV Construct 
V1/2 act (mV) Vmax(mV) 
f-value at r50 f-value at r300 
LF WT (IQDY) -34.04 ± 0.67 (18) -12.67 ± 0.86 (18) 0.20 ± 0.03 (8) 0.30 ± 0.04 (8) 
LF MQDY -29.05 ± 1.08 (13) a -6.99 ± 1.27 (13) a 0.083 ± 0.002 (5) a 0.25 ± 0.03 (5) 
LF IQDC -28.91 ± 0.63 (13) a -6.82 ± 0.83 (13) a 0.10 ± 0.03 (9) a 0.27 ± 0.01 (9) 
LF MQDC -28.70 ± 1.02 (10) a -7.21 ± 1.21 (10) a 0.10 ± 0.01 (5) b 0.24 ± 0.03 (5) 
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bottom red; and Figure 2.11D), with a decreased depolarization rate preceding Na 
action potentials (Figure 2.11C).  This suite of effects in the ADAR2-deficient 
setting is consistent with a loss of RNA editing leading to increased CaV1.3 CDI, with 
corollary diminution of CaV1.3 pacemaking current.   
The ‘wildtype’ GluR-BR/R mice used as baseline were engineered for 
constitutive expression of the R-containing form of GluR-B subunits at the 
Q/R-editing site (Higuchi et al., 2000); hence, the alteration of Na spike activity seen 
upon transitioning to ADAR2 knockout animals (Figures 2.11B-2.11D) could not 
have arisen trivially from a loss of Q/R editing of GluR-B subunits.  Nonetheless, the 
result could still be confounded by the altered editing states of other ADAR2 
substrates upon ADAR2 knockout.  Accordingly, we analyzed the actions of ADAR2 
elimination upon a persistent pattern of membrane potential oscillations that persists 
after application of a saturating concentration of TTX, as illustrated by the exemplar 
trace from a wildtype GluR-BR/R mouse (Figure 2.11E, upper black trace).  These 
repetitive ‘Ca spikes’ reflect a more readily defined role for L-type channels, because 
these spikes arise from a simpler system wherein oscillations are generated by 
recurring depolarization via L-type Ca2+ current that in turn gives rise to an ensuing 
phase of repolarization via Ca2+-activated K currents (Pennartz et al., 2002; Belle et 
al., 2009). In addition, the occurrence of the calcium spikes at around -55 mV hinted 
the involvement of low threshold CaV1.3 current rather than CaV1.2 which activates at 
much higher voltage. Importantly, while representing a simpler phenomenon, the 
firings of Ca spikes display day-night regulation closely correlating with the more 
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integrated Na spike behavior (Pennartz et al., 2002).  Significantly, then, the sample 
trace from an ADAR2-deficient mouse (Figure 2.11E, middle red record) exhibited a 
reduced frequency of Ca spikes, concurrent with slower depolarization of troughs 
between spikes.  Population data averaged from several SCN slices confirmed the 
attenuated Ca spike frequency upon ADAR2 elimination (Figure 2.11G); and 
corresponding averages of time-aligned Ca spikes confirmed depolarization of 
troughs between Ca spikes (Figure 2.11F).  Both effects of ADAR2 elimination 
agree with heightened CaV1.3 CDI and resultant attenuation of CaV1.3 current.  In 
particular, diminished low-threshold depolarizing current explains the decrement in 
Ca spike frequency, while reduced Ca2+ entry during spikes would moderate 
Ca2+-activated K current and thereby slow down repolarization between Ca spikes 
(Bowden et al., 2001).  Indeed, the role of CaV1.3 current in driving Ca spikes was 
explicitly confirmed by abolishing spontaneous fluctuations with the L-type channel 
inhibitor nimodipine (Figure 2.11E, bottom red trace).  In all, this spectrum of effects 
on the simpler system of Ca spikes hinted more strongly that RNA editing of CaV1.3 
channels contributes to the altered SCN rhythmicity upon loss of ADAR2.   
To further establish the role of CaV1.3 current in mediating Ca spikes we 
investigated the actions of Bay K 8644, a highly-selective, L-type-channel-specific 
agonist.  Though this compound has been available for some time, particularly 
relevant aspects of its actions have only recently become clear.  Importantly, beyond 
its well-known ability to augment overall current, this compound also diminishes 
Ca2+-dependent inactivation (CDI) via increasing the open probability of CaV1.3 
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channels (Tadross et al., 2010).  Given this functional profile, Bay K 8644 should act 
much like a selective pharmacological mimic of altered CaV1.3 IQ-domain editing.  
In particular, this compound should simulate the transition from an ADAR2 knockout 
context (more CDI and less current) to a wild-type context (less CDI with more 
current)  so long as RNA-editing-induced alteration of Ca spiking does arise from 
modified CaV1.3 CDI.  Indeed, we observed a striking analogy between the effects 
of Bay K 8644 (Figure 2.11H-2.11J) and those produced upon transitioning from 
knockout to wild-type mice (Figure 2.11E-2.11G).  Specifically, 0.5 to 1 μM Bay K 
8644 produced both an increase in overall Ca spike rate, and hyperpolarization of 
troughs between Ca spikes.  More precisely, Bay K 8644 mimicked an exaggerated 
wild-type phenotype, in which reduction of CDI by RNA editing was enhanced 
beyond the normal wild-type level.  In all, these effects of Bay K 8644 on SCN Ca 
spikes, highly analogous to those in our transgenic experiments, argue well that RNA 
editing of CaV1.3 channels modulates SCN rhythmicity. The Bay K 8644 experiment 
was performed using the normal C57BL/6 mice acquired commercially due to the 
limited number of ‘wildtype’ GluR-BR/R animals. Although editing of GluR-BR/R in 
normal mice is also close to 100%, a slower frequency of the calcium spikes was 
observed in normal mice as compared to the ‘wildtype’ GluR-BR/R mice (Figure 2.11 




Figure 2.11 Comparison of SCN rhythmicity in wild-type and ADAR2 knockout mice. A. 
Analysis of RNA editing of CaV1.3 IQ domain in mouse SCN.  Format as in Figure 2.4. B. Na 
spikes in wildtype (WT, top black) and knockout mouse (KO, bottom red) SCN neurons. C. 
Overlays of time-aligned Na spikes from preparation in panel B, confirming diminished 
depolarization prior to Na spikes in KO mice.  Solid lines represent graphically the mean 
depolarization rate averaged over multiple spikes.  Symbols plot mean depolarization rate 
(±SEM) preceding Na spikes in exemplar wild-type versus KO mouse presented in panel B.  D. 
Average frequency of action potential (Na spikes) in wild-type (n = 6) versus KO (n = 10) mouse 
SCN neurons.  Upper scale tick, 1 Hz. Asterisk denotes significance at P < 0.05 level. E. Ca 
spike activity (in 1 M TTX) recorded in wildtype (top, black) versus knockout mouse SCN 
neurons (bottom, red).   In the knockout, Ca spike frequency is decreased, and troughs are 
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depolarized. Red trace at extreme bottom shows abolition of Ca spikes by 10 μM nimodipine.  F. 
Time-aligned, averaged Ca spikes confirm that KO mouse neurons manifest a depolarization of 
minimal troughs between spikes.  Data averaged from n = 6 WT and n = 7 KO mouse SCN slices.  
Bars, standard error of mean. G. Decreased average frequency of Ca spikes in wild-type versus 
KO mouse SCN slices analyzed in panel F (p < 0.01).  Format as in panel D. H. Exemplar Ca 
spikes from wild-type mouse SCN slice, illustrating effect of Bay K 8644 to increase spike 
frequency and deepen troughs between spikes. I. Time-aligned, averaged Ca spikes confirm that 
Bay K 8644 deepens troughs between Ca spikes.  Averaged from n = 11 mouse SCN slices.  
Format as in panel F. J. Increased average frequency of Ca spikes in wild-type SCN slices 
exposed to 1M Bay K 8644 (P < 0.05), averaged from same slices as analyzed in panel I.  
Format as in panel D. 
 
 
Figure 2.12 Effects of kainate on Ca2+ spike activity in wild-type mouse SCN neurons. A. 
Exemplar Ca spikes illustrating effects of 5-10 M kainate, suggesting that kainate increases Ca 
spike frequency, while depolarizing troughs between Ca spikes. B. Population data confirm these 
trends: averages of time-aligned Ca spikes indicate depolarization of troughs by kainate (black 
versus red).  C. Averages of Ca spike frequency confirm that kainate augments spike frequency 
Format as in Figure. 2.11E.    
 
2.4 Discussion  
Adenosine-to-inosine RNA editing post-transcriptionally recodes genomic 
information to generate mRNA and protein diversity. Many of the identified 
mammalian editing targets were found in the nervous system. The family of GluR ion 
channels and serotonin 2C receptors (Schmauss, 2003; Seeburg and Hartner, 2003) 
are among the earliest ADARs substrates discovered and have been extensively 
studied.  Beyond these historical focuses, the list of editing targets is expanding with 
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the recent discovery of editing in mammalian KV1.1 channel (Bhalla et al., 2004) and 
GABAA-α3 receptor (Ohlson et al., 2007; Rula et al., 2008) resulting in altered 
protein functions. Notably, outside of CaV1.3 channels, there are instances of CaV 
channel editing exclusive of the IQ domain, though with uncharacterized biophysical 
consequences (Smith et al., 1998; Kawasaki et al., 2002; Tsunemi et al., 2002; 
Hoopengardner et al., 2003; Keegan et al., 2005). Here, our discovery of RNA editing 
within the CaV1.3 IQ domain represents a significant expansion to this group, given 
the robust functional modulation of Ca2+-dependent feedback control at this particular 
locus, and the broad range of biological roles served by these channels 
(Sinnegger-Brauns et al., 2004; Day et al., 2006; Striessnig et al., 2006).  
RNA editing of CaV1.3 was restricted to the IQ domain where three closely 
spaced codons are recoded from ATA to ATG, CAG to CGG and TAC to TGC. In rat 
and mouse, ATA/ATG and TAC/TGC sites are edited at much higher efficiency as 
compared to CAG/CGG site (Figure 2.1 and 2.4). Interestingly, human displayed a 
slightly different pattern of editing as only significant ATA/ATG change was observed 
(Figure 2.3A) despite the conservation of signature RNA duplex structure and high 
sequence similarity in the ECS and edited site in the three species (Figure 2.7). 
Previous study indicated that an in-frame inclusion of Alu cassette, encoded by exon 
5a, specifically in the catalytic domain resulted in the production of a human ADAR2 
isoform with 50% reduction in catalytic activity (Gebhart et al., 2010). In comparison, 
inclusion of 30-nt Alu sequence due to alternate usage of 3' splice acceptor site in 
intron 5 of mouse ADAR2 greatly enhanced catalytic activity of the enzyme (Rueter 
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et al., 1999). It would therefore be interesting to determine whether species specific 
splicing patterns in the catalytic domain of ADAR2 also lead to different substrate 
specificity. 
The minigene system used in this study furnished a useful assay for 
identifying ECS and further investigation of the mechanism of RNA editing. 
Co-transfection of pRK5-gIQECS with varying amounts of 
pIRES2-AcGFP1-ADAR2 vector produced robust editing at ATA and TAC codon and 
little editing in CAG codon, fitting closely with the observation in native rat and mice 
CNS tissues. On the other hand, similar experiment performed with pRK5-gIQΔECS 
vector without the ECS sequence resulted in completely elimination of editing, thus 
confirming the importance of the ECS sequence in the formation of RNA duplex 
structure that supports ADAR2-mediated RNA editing. Editing of ATA and TAC 
codon exhibited dose dependent manner, correlating strongly with the ratio of 
ADAR2 to minigene transfected (Figure 2.5C). Similarly, developmental study of 
editing of various substrates in a study by Jacobs et al., 2009 revealed a general 
correlation of editing level and expression level of ADAR1 and 2. Lastly, the integrity 
of secondary RNA structure at the edited sites appears to be crucial for correct editing. 
Disrupting the base pairing of ATA and CAG codons that lie on the stem loop as in 
M1 and M2 mutation, resulted in significant reduction of editing in ATA and TAC 
(Figure 2.6C) while restoring the base-paring of TAC codon in M3 mutation 
selectively reduced editing specifically in TAC codon (Figure 2.6C) suggesting that 
the catalytic domain of ADAR2 recognizes specific folding at the action site and lacks 
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preference for stem or loop structure.  
Nonetheless, despite traditional belief that ADAR-mediating editing is not 
sequence specific, an increasing number of studies recently have indicated a possible 
nucleotide sequence bias surrounding the edited site which determines editing 
efficiency (Bhalla et al., 2004; Dawson et al., 2004). However, no consensus sequence 
has been conclusively proposed so far. More strikingly, recent study by Stelf et al., 
2010 showed dsRBM (double stranded RNA binding motif) of ADAR2 interacted 
with both the nucleotide base and phosphate backbone of the RNA duplex structure of 
Glur-B substrate. Mutation of the relevant bases disrupted dsRBM-RNA binding and 
mutating the amino acid residues in dsRBM responsible for interacting with bases 
reduced editing level. The study thus provided a structural basis for the sequence 
determinant hypothesis. As different substrates were often found to be edited at 
different efficiencies in native tissues (Jacobs et al., 2009), it would therefore be 
interesting to see if such dsRBM-base interaction would be detected in other edited 
substrates, in particular, CaV1.3 and if the extent of dsRBM-base interaction 
determines substrate preference for ADAR2. Subsequent sequence alignment of 
multiple edited substrates in the sequence responsible for dsRBM binding would 
eventually produce a consensus sequence which allows for prediction of ADARs 
targets.  
Most intriguingly, IQ-domain editing is observed in all CNS tissues screened 
so far but not in other peripheral tissues such as heart and pancreas where α1D 
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transcripts are also expressed. First of all, lack of expression of ADAR2 enzyme in 
glial cells (Jacobs et al., 2009) and lack of IQ-domain editing in dorsal root ganglion 
(Figure 2.1D, top panel) rule out the possibility of astrocyte origin of IQ-domain 
editing and suggest that IQ-domain editing is CNS and neuronal specific. On the other 
hand, abundant expression of ADAR2 in tissues such as pancreatic beta cells 
correlating with robust editing of GluR-B subunit would therefore suggest some 
regulatory mechanisms other than the lack of ADAR2 activities are required to 
explain such “all or none” phenomenon. In line with this, several possibilities warrant 
further consideration. Firstly, certain splice isoforms of ADAR2 which selectively 
disfavor editing in CaV1.3 could be dominantly expressed in peripheral tissues and 
indeed alternative splicing in the catalytic domain of ADAR2 was known to alter its 
catalytic activity and perhaps also target selection (Gerber et al., 1997; Rueter et al., 
1999).  Secondly, binding of other dsRBM-containing protein to the IQ-ECS duplex 
would preclude the binding of ADAR2. Consequently, tissue specific expression of 
such factors in peripheral tissue would then compromise IQ-domain editing. For 
example, DICER, well known for its ability to cleave dsRNA, has been shown to 
compete with ADAR2 for the binding to the same microRNA substrates (Yang et al., 
2006; Kawahara et al., 2007).  
Functionally, IQ-domain editing results in amino acid changes from I to M, Q 
to R and Y to C yielding total seven amino acid combinations including the WT IQDY 
as revealed by screening of individual cDNA clones (Figure 2.2). The I/M or Q/R or 
IQ/MR changes resulted in substantial slow-down of CDI with the strongest effect 
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seen in MR. Interestingly, Y/C change which had no noticeable functional impacts in 
short-form CaV1.3 channels significantly attenuates CDI in the long-form background 
potentially due to the weaker binding between IQ helix and calmodulin in the 
presence of ICDI. In comparison, the substantially diminished CDI observed upon 
recoding either one or both of the isoleucine and glutamine residues in CaV1.3 
channels could not be fully accounted for by the disruption of calmodulin binding. 
Although structural data also revealed substantial interaction of isoleucine and 
glutamine with calmodulin, their role in anchoring calmodulin may not be essential in 
the presence of the other three aromatic anchoring sites (Van Petegem et al., 2005). 
Alternatively, the data here supports the notion that the isoleucine and glutamine 
residues function importantly as an effector site for Ca2+/C-lobe regulated CDI 
(Erickson et al., 2003; Liang et al., 2003; Kim et al., 2004). While the detailed 
structural rearrangement during CDI is unknown, a parsimonious hypothesis is that 
conformational changes allows for exposure of IQ di-peptide for interaction (Kim et 
al., 2004) with still unknown sites of the channel, leading eventually to an allosteric 
inhibition of channel opening (Tadross et al., 2010).  
As a first step towards understanding the neurobiological consequences of 
IQ-domain editing, we have focused upon the suprachiasmatic nucleus (SCN), where 
CaV1.3 currents modulate spontaneous action potentials underlying mammalian 
circadian rhythms (Pennartz et al., 2002). An initial observation of slower action 
potential firing frequency in WT as compared to ADAR2 KO mice clearly 
demonstrated the RNA editing modulates SCN rhythmicity (Figure 2.11B). 
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Specifically, subsequent experiments with the more CaV1.3-relevant Ca spike 
oscillations further suggested that editing of CaV1.3 channels appreciably mediated 
this modulation. In WT SCN neurons, higher frequency of Ca spikes and faster 
depolarizing phase of Ca spike implied a more sustained low threshold driving current. 
On the other hand, enhanced activity of Ca2+-activated K channels (Bowden et al., 
2001) subsequent to the prolonged calcium entry via CaV1.3 then explained the 
sharper decay of ensuing repolarizing phase and hyperpolarizing trough between 
spikes (Figure 2.11E to G). In line with this hypothesis, pharmacological block of 
CaV1.3 currents eliminated the calcium spikes and further modulation of CDI by Bay 
K 8644 mirrored the effect of editing (Figure 2.11H to J).   
Despite the support from the empirical data, the suggestion that editing of 
CaV1.3 modulates SCN rhythmicity deserves further discussion, given the presence of 
various potential editing targets in SCN.  Firstly, the literature is rather divided 
regarding the role of L-type Ca2+ channels in modulating SCN activity.  While 
earlier studies (Pennartz et al., 1998; Pennartz et al., 2002) favor a substantial 
contribution of L-type Ca2+ channels to SCN pacemaking, a more recent investigation 
emphasizes a more subsidiary influence of these channels (Jackson et al., 2004).  
This seeming discrepancy may relate to differences of slice (Pennartz et al., 1998; 
Pennartz et al., 2002; Ikeda and Dunlap, 2007) versus isolated neuron preparations of 
SCN (Jackson et al., 2004).  Fitting with this view, a similarly diminished role of 
voltage-gated Ca2+ channels in shaping cerebellar pacemaking has been observed 
between slice (Womack et al., 2004) and isolated neuron experiments (Raman and 
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Bean, 1999).  Indeed, our own experiments favoring a significant role of CaV1.3 
were performed in the presumably more intact acute slice configuration.  
Secondly, as for differences in SCN rhythmicity observed between WT and 
ADAR2-deficient mice (Figure 2.11E), our data argue well for the sufficiency of 
altered CaV1.3 CDI to contribute to these differences (Figures 2.11H-2.11J), and also 
exclude Q/R editing of GluR-B subunits as the causative mechanism as both WT and 
ADAR2 KO mice constitutively expressed R form of GluR-B.  Nonetheless, other 
potential editing targets remain to be considered.  Could altered Q/R editing of 
kainate receptors modify SCN activity upon ADAR2 elimination (Herb et al., 1996)?  
Countering this possibility, addition of kainate to wild-type SCN slices increased Ca 
spiking frequency while depolarizing troughs between spikes (Figure 2.12), 
contradicting the outcome seen upon transitioning from KO to WT contexts (Figure 
2.11E-2.11G).  Could editing of serotonin receptors explain our findings?  
Suprachiasmatic nucleus neurons are innervated densely by serotonergic projection 
from raphe nuclei and the serotonin input was known to mediate the light induced 
phase shift of the circadian rhythm. It has been shown that selective activation of 
5-HT2c only at early subjective night CT16 resulted in phase delay of day-night cycle 
(Varcoe and Kennaway, 2008). However as both WT and KO mice were housed with 
exactly the same 12 hour day and night light scheme, there should not be phase 
difference in the circadian rhythm between these two groups of animal. Furthermore, 
it is the serotonin HT-7 receptor subtype that mediates serotonin effects in SCN and 
there is no indication that HT-7 is edited like the HT-2C receptor subtype (Lovenberg 
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et al., 1993). Could editing of GABA receptors contribute? GABA can certainly 
regulate SCN activity (Gillespie et al., 1997; Mintz et al., 2002), and GABA receptors 
undergo RNA editing by ADAR2 (Ohlson et al., 2007).  Opposing this hypothesis, 
only the α3 subunit of GABAA receptors is known to be edited (Ohlson et al., 2007), 
and the α3 subunit is only sparsely expressed in the adult mice relevant to our studies 
(O'Hara et al., 1995).  Finally, might editing of voltage-activated K+ channels play a 
role?  Against this position, only KV1.1 channels are known to be RNA edited 
(Bhalla et al., 2004), while SCN neurons have been reported to express KV3.1(Itri et 
al., 2005; Espinosa et al., 2008), KV3.2 (Itri et al., 2005), KV4.1 and KV4.2 (Itri et al., 
2010).  In fact, KV1.1 knockout mice exhibit intact circadian rhythms, so long as 
overt seizure activity is controlled (Fenoglio-Simeone et al., 2009).  Overall, then, 
while comprehensive exclusion of alternative mechanisms is difficult to achieve, our 
data remain highly suggestive that RNA editing of CaV1.3 CDI influences SCN 
rhythmicity.   
Beyond the SCN, editing the CaV1.3 IQ domain could also to modulate 
numerous other brain regions such as substantia nigra pars compacta (SNc) where 
low-voltage activated CaV1.3 current contributes to neuronal excitability and 
pacemaking (Olson et al., 2005; Chan et al., 2007). Indeed, robust editing of CaV1.3 
IQ domain was observed in human substantia nigra (Figure 2.3). While autonomous 
action potential activity of SNc neurons supports normal motor function (Hodge and 
Butcher, 1980), predominance of CaV1.3 current in driving pacemaking heightens 
onset of Parkinson’s disease under pathological condition. It could therefore be 
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possible that RNA editing of CaV1.3 IQ domain, through controlling the calcium 
influx, serves to maintain a balance between supporting the normal motor control and 
minimizing cellular damage due to Ca2+ overload. Lastly, it would be interesting to 
evaluate whether CaV1.3 editing may contribute to epilepsy, depression, and suicidal 
tendency as these neurological disorders have been found to be associated with a 
generalized dysregulation of brain RNA editing (Gurevich et al., 2002; Schmauss, 
2003). Investigating the role of edited CaV1.3 channels in these and other 
neurobiological processes now allows for further mechanistic advance and disease 






















Functional characterization of alternative splicing in IS5-IS6, 








3.1 Background and objectives 
Alternative splicing of CaV1.3 channels serves to regulate channel function 
and already, the extensive alternative splicing in the C-terminus has been associated 
with altered CDI profile (Shen et al., 2006; Singh et al., 2008) and differential 
modulation of channel properties by PKA (Ramadan et al., 2009) and G-proteins 
(Zhang et al., 2005). In comparison, the functional impacts of alternative splicing in 
other channel regions remain relatively unknown.  
Previous studies have reported on the characterization of some of the 
alternatively spliced exons in the IS5-IS6, I-II loop and IVS3-IVS4 regions. However 
the results appeared to be inconsistent and ambiguous. Whereas Koschak et al., 2001 
reported that a α1D channel isoform containing exon 8a cloned from human pancreatic 
tissue failed to express and lack any functional currents, Xu and Lipscombe, 2001 
showed a rat brain CaV1.3 channel isoform expressing exon 8a supported robust 
current despite the fact that exon 8a of both human and rat share 100% sequence 
similarity. In addition, although Xu and Lipscombe, 2001 attempted to characterize 
both the electrophysiological and pharmacological properties of several splice 
isoforms including deletion of exon 11 and deletion of exon 32 in the context of long 
form CaV1.3 channel, their result could possibly be confounded by the 
loss-of-function mutation in the ICDI domain. Intact ICDI domain in long form 
CaV1.3 channel affects not only CDI profile of the channel but also the activation and 
inactivation properties. Furthermore as the DHP sensitivity L-type calcium channel is 
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influenced by the kinetic of channel inactivation, it is therefore important to revaluate 
both the electrophysiological and pharmacological properties of different splice 
channel isoforms with functional ICDI domain.  
More importantly, as exon inclusion and exclusion is often not 100%, 
quantifying the tissue distribution frequency of alternatively spliced exons would help 
identify dominant splice isoforms expressed in a tissue-specific manner. Once 
equipped with the knowledge of unique properties of different channel splice isoforms, 
one could then make prediction of cellular or tissue physiology. Unfortunately, 
although extensive splicing patterns of CaV1.3 channels has been reported, tissue 
specific distribution frequency data of alternatively spliced exons remains lacking.  
As a start to address these gaps of knowledge, the study here focused first on 
screening and quantifying the distribution frequency of alternatively spliced exons in 
several splicing hot spots including IS5-IS6, I-II loop and IVS3-IVS4 in both rat brain 
and heart tissue. Secondly we aimed to characterize the electrophysiological and 
pharmacological properties of these splice isoforms by patch-clamp 
electrophysiological recordings in transiently transfected HEK 293.  
3.2 Materials and methods 
Transcript scanning for splicing in IS5-IS6, I-II loop and IVS3-IVS4 region 
Two cDNA libraries Rat Heart Marathon-Ready™ cDNA and Rat Brain 
Marathon-Ready™ cDNA (Clonetech) were used as templates for PCR across two 
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regions including first IS5-IS6, I-II loop region and second IVS3-IVS4 region 
respectively. The primers used for amplifying IS5-IS6, I-II loop region include sense 
primer: 5’- CTTTGCCATGCTCACTGTGT-3’;  
and antisense primer: 5’- CCAGTCTGGCTGATTGTAGTGCTC-3’  
while the primers used for amplifying IVS3-IVS4 region include sense primer: 5’- 
ATCTCCATCTTCTTCATTAT -3’;  
and antisense primer: 5’- TGAAGGTCCATAGCAGAGT -3’. Colony screening was 
performed by first sub-cloning PCR products into pGEM-T Easy vector (Promega, 
Madison, WI), transforming them into DH10B Escherichia coli cells, and then 
sending ~40 randomly isolated clones for automated DNA sequencing.  
Construction of splice isoform of CaV1.3 Calcium channel 
The splice isoforms CaV1.3LF E8 and CaV1.3LF ΔE11 were constructed by replacing 
AleI/BamHI fragments containing exon 8 and deletion of exon 11 respectively into the 
reference CaV1.3LF A2123V construct while the splice isoforms CaV1.3LF E31, CaV1.3LF 
E31E32 and CaV1.3LF E31aE32 were constructed by replacing BamHI/BstEII fragments 
containing exon 31, exon 31 exon 32 and exon 31a exon 32 respectively into the 
reference CaV1.3LF A2123V construct. All expression vectors were confirmed by DNA 
sequencing before transfected into HEK293 cells for electrophysiological 
characterization.  
Whole-cell patch-clamp electrophysiology and data analysis 
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Protocols for recording stepwise current and recovery from CDI were reported in 
section 2.2. In addition, Gnorm curves were obtained from a tail activation protocol 
performed with Ba2+ as charge carrier (Figure 3.3 and 3.4, bottom panels). The cells 
were activated by a family of 20-ms test pulses (-60 mV to 80 mV in increments of 10 
mV), and tail currents were measured upon repolarization to -50 mV following each 
step.  Steady-state inactivation curves (Inorm, SSI) (Figure 3.3 and 3.4, bottom panels) 
were obtained with the following protocol: stepping from a holding potential of -90 
mV to an initial -10 mV test pulse lasting 30 ms, followed by a family of 15-s 
prepulses (-120 mV to 20 mV in increments of 10 mV), in turn followed by a 104-ms 
test pulse to -10 mV.  Each steady-state inactivation relation was normalized to the 
maximal current amplitude.  
Activation curves (Figure 3.3 and 3.4, bottom panels) were fitted by a dual Boltzmann 
function:  
Gnorm = Flow /  ( 1 + exp( -(V1⁄2,low - V) / klow) ) + (1 - Flow) / ( 1 + exp( -(V1⁄2,high -V) / 
khigh) ) 
where Gnorm is the normalized tail current; Flow is the fraction of the low-threshold 
component; V is the membrane potential of the test pulse; V1⁄2,low, V1⁄2,high, klow, and 
khigh are the half-activation potentials and slope factors for the low- and high-threshold 
components, respectively.  V1⁄2act  is the potential for half-activation calculated from 
dual Boltzmann functions when Gnorm = 0.5. 
The steady-state inactivation data (Figure 3.3 and 3.4, bottom panels) were fitted with 
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a single Boltzmann equation 
I  /Imax= Imin + (Imax - Imin) / ( 1 + exp((V1/2 - V) / k) ) 
where I/Imax  is the normalized current; V1/2 is the potential for half-inactivation, and k 
is the slope factor.  
Drug Preparation 
Stock solutions were prepared by dissolving nimodipine (RBI) in 100% ethanol. 
Nimodipine was protected from light during these procedures.  
3.3 Results 
Tissue specific alternative splicing patterns in rat brain and heart  
The splicing pattern in IS5-IS6, I-II loop and IVS3-IVS4 was quantified by 
the transcript-scanning method (Soong et al., 2002; Tang et al., 2004). PCR amplicons 
spanning exons 7 to 14 (Figure 3.1A) were amplified from rat brain and heart cDNA 
libraries respectively and subsequently resolved by electrophoresis in 2% agarose gel. 
Two distinct bands differing by size of approximately 50 bp were observed for rat 
brain (Figure 3.1B). The lower band of approximately 600 bp indicated the existence 
of exon combination of 7, 8 or 8a, 9, 10, 12, 14 which is of size of 598 bp, as 
predicted from rat CaV1.3 genomic sequence while the upper band of approximately 
650 bp correlated with additional inclusion of exon 11 (60 bp). In contrast, an 
additional band of approximately 720 bp was observed for rat heart indicated the 
further inclusion of either exon 9* (84 bp) or exon 13 (90 bp). However it would be 
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hard to identify the different combination of alternatively spliced exons due to the fact 
that agarose gel has limited resolving capability and exons 8 and 8a are of equal 
length. Therefore subsequently, PCR bands for respective tissues were excised 
together, gel purified were cloned into pGEM-T Easy vector and transformed into 
DH10B bacteria before DNA amplified from around 40 randomly selected clones 
were analysed by DNA sequencing. Three sites of alternative splicing were observed 
including mutually exclusive exon 8/8a and alternate exon 9* and 11 in both rat brain 
and heart while alternate exon 13 was not detected in either tissue. Subsequent colony 
counting revealed that exon 8 (43.2% inclusion) and 8a (56.8% inclusion) were 
almost evenly distributed in brain (Figure 3.1D, top) while exon 8a (86.5% inclusion) 
was dominantly expressed in heart (Figure 3.1E top), corroborating with previous 
report in human heart (Baig et al., 2011). Exon 9* was expressed at very low level 
(2.7% inclusion in brain and 5.4% inclusion in heart) and lastly exon 11 has equal 
expression level in brain and heart (Figure 3.1D and E, top). The existence of three 
alternatively spliced exons in the IS5-IS6 and I-II loop regions suggested the 
occurrence of possibly eight combinations. However, only five combinations were 
detected in brain and heart respectively. While the combinations 8/-11 (inclusion of 
exon 8 and deletion of exon 11), 8a/-11, 8/11 and 8a/11 were commonly found in both 
brain and heart (Figure 3.1D and E, bottom), 8a/9*/-11 was found only in the brain 
(Figure 3.1D, bottom) and 8a/9*/11 was detected specifically in the heart (Figure 3.1E, 
bottom), therefore explaining the top band (around 720 bp) observed in the PCR 
products from rat heart detected in agarose gel (Figure 3.1B).      
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On the other hand, amplicons spanning exon 30 to 33 (Figure 3.2A) were 
also PCR-amplified from rat brain and heart cDNA libraries. The PCR products for 
both brain and heart appeared as a single band of the size of approximately 650 bp, 
although visual inspection indicated the amplicon amplified from rat heart was of 
lower band size (Figure 3.2B). Subsequent analysis of cDNA clones from rat brain 
showed that exon 31a were found be more dominantly expressed in both brain (68.3% 
inclusion) and heart (72.5% inclusion) (Figure 3.2D and E, top). Furthermore while 
exon 32 was found to be dominantly expressed in brain (92.7% inclusion), it was only 
included at 30% in the heart. Interestingly, colony screening help identified an 
additional exon of 12 nucleotide inserted between exon 31/31a and exon 32 (Figure 
3.2C). The new exon which codes for 4 amino acids, KIVA, was named exon 31* in 
the study and found to be included in 7.5% in heart but not in the brain (Figure 3.2D 
and E top). In addition, subsequent analysis of individual cDNA clones revealed three 
combination of 31a/-32, 31/32 and 31a/32 in the brain while exon 31* further 
amplified the coding diversity of α1D transcripts in heart and total five splice variants 




Figure 3.1 Tissue-specific splicing patterns of IS5-IS6 and I-II loop in rat brain and heart. A. 
Schematic diagram showing relative position of mutually exclusive exon 8 and 8a, alternate exon 
9*, 11 and 13. PCR amplicon was amplified from brain and heart cDNA library across the region 
spanning exon 7 to 14 flanked by red borders and indicated at the bottom. B. PCR detected two 
bands (around 600 bp and 650 bp) and three bands (around 600 bp, 650bp and 720 bp) in brain 
and heart respectively, indicating the existence of different splice variants. C. Subsequent DNA 
screening of around 40 cDNA clones detected mutually exclusive exon 8 and 8a, alternate exon 9* 
and exon 11 as highlighted in black. Constitutive exon 7, 9 10 and 12 are shown in grey. D. 
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Summary of relative inclusion of different alternatively spliced exon 8/8a, 9* and 11 (top) and 
combination (bottom) from DNA sequencing of rat brain cDNA clones. E. Summary of relative 
inclusion of different alternatively spliced exon 8/8a, 9* and 11 (top) and combination (bottom) 
from DNA sequencing of rat heart cDNA clones.    
 
 
Figure 3.2 Tissue-specific splicing patterns of IVS3-IVS4 in rat brain and heart. A. Schematic 
diagram showing relative position of mutually exclusive exon 31 and 31a, alternate exon 32. PCR 
amplicon was amplified from brain and heart cDNA library across the region spanning exon 30 to 
33 flanked by red borders and indicated at the bottom. B. PCR detected seemingly one band 
(around 650 bp) in brain and heart respectively. C. Subsequent DNA screening of around 40 
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cDNA clones revealed the presence of mutually exclusive exon 31 and 31a, a newly identified 
alternate exon 31* and exon 32 as highlighted in black. Constitutive exon 30 and 32 are shown in 
grey. D. Summary of relative inclusion of different alternatively spliced exon 31/31a and 32 (top) 
and combination (bottom) from DNA sequencing of rat brain cDNA clones. E. Summary of 
relative inclusion of different alternatively spliced exon 31/31a, 31* and 32 (top) and combination 
(bottom) from DNA sequencing of rat heart cDNA clones. 
 
Altered electrophysiological properties due to alternative splicing in IS6 and I-II loop 
and domain IV of CaV1.3 
As a start to characterize the properties of the dominant splice isoforms 
observed in rat heart and brain, expression vectors for several splice channel variants 
were generated based on CaV1.3LF A2123V construct. The corrected long-form construct 
CaV1.3LF A2123V express alternatively spliced exon 8a, 11, 31a and Δ32 (deletion of 
exon 32). Exon 8a was replaced with exon 8 in the splice isoform CaV1.3LF E8, while 
exon 11 was excluded in the construct CaV1.3LF ΔE11. Exon 31a was replaced with 
exon 31, exon 31 and exon 32, exon 31a and exon 32 in CaV1.3LF E31, CaV1.3LF E31E32 
and CaV1.3LF E31aE32 respectively. The suite of different splice isoforms was then 
co-transfected with β2a and α2 subunits into HEK 293 for whole　 -cell 
electrophysiological recordings.  
Figure 3.3 reports the electrophysiological properties of CaV1.3 splice 
variants CaV1.3LF E8 and CaV1.3LF ΔE11. The profile of splice variant CaV1.3LF E8 is 
shown in Figure 3.3B. The V1/2act (potential for half activation) as estimated by the I-V 
relationship (Inorm, IV) is positively shifted by 6.4 mV as compared to the reference 
CaV1.3LF A2123V (Figure 3.3A and B, fourth panel and Table 3.1). Further detailed 
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analysis of tail current yields the Ba2+ tail-activation relation (Gnorm) confirming the 
depolarized shift of activation property (Figure 3.3B fifth panel and Table 3.1, 
CaV1.3LF E8: V1/2 act = -13.15 ± 1.43 mV; CaV1.3LF A2123V : V1/2 act = -19.66 ± 1.42 mV). 
In contrast, V1/2 inact derived from steady state inactivation (Inorm, SSI) remains 
unchanged as compared to CaV1.3LF A2123V. (Figure 3.3A and B, fifth panel and Table 
3.1). In addition, CaV1.3LF E8 did not significantly affect CDI as compared to CaV1.3LF 
A2123V although Ca2+ relation appeared to shift to the right (Figure 3.3B, second panel) 
possibly due to a depolarized shift of activation and lastly multi-second recovery from 
CDI remains unaffected as well (Figure 3.3B, second panel).  
On the other hand, V1/2 act of CaV1.3LF ΔE11 determined by tail current analysis 
was positively shifted by 16.21 mV as compared to CaV1.3LF A2123V (Figure 3.3C, fifth 
panel and Table 3.1). The Ca2+ relation was similarly shifted to the right (Figure 3.3C, 
second panel) while recovery and steady state inactivation properties were not 
significantly altered. The narrow window current due to the more depolarized shift of 
activation as observed in both CaV1.3LF E8 and CaV1.3LF ΔE11 splice isoforms restrict 
the operating range of the channels to more depolarized voltage. As both splice 
isoforms required stronger voltage stimulus for opening, selective post-synaptic 
expression of such CaV1.3 splice isoforms especially CaV1.3LF ΔE11 could then 
potentially desensitize the synapse to weaker stimuli. 
Figure 3.4 details the electrophysiological characterization of CaV1.3LF E31, 
CaV1.3LF E31E32 and CaV1.3LF E31aE32 as compared to CaV1.3LF A2123V. Surprisingly, none 
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of the parameters studied including CDI, VDI, recovery, V1/2 act or V1/2 inact were 
significantly affected by the alternative splicing in the region of IVS3-IVS4 region 
(Figure 3.4 and Table 3.1). 
 
Figure 3.3 Electrophysiological properties of splice isoforms CaV1.3LF E8 and CaV1.3LF ΔE11 as 
compared to CaV1.3LF A2123V. A. Channel gating properties of CaV1.3LF A2123V. Top panel to fourth 
panel were reproduced from Figure 2.10A. Fifth panel, Ba2+ tail-activation curves (Gnorm) and Ba2+ 
steady state inactivation curve (Inorm,SSI).  For second through bottom panels, s.e.m. bars are 
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shown when larger than symbol size. B. Gating profile for channel variant CaV1.3LF E8.  Format 
as in A. CaV1.3LF A2123V profiles were reproduced as gray dash curves from second through bottom 
panel. The f value and fractional recovery unchanged. Activation gating shifted significantly to the 
right as shown in bottom two panels while inactivation not significantly different. C. Gating 
profile for CaV1.3LF ΔE11 channel variant. Format as in B. The f value and fractional recovery 
unchanged. Activation gating shifted significantly to the right as shown in bottom two panels 




Figure 3.4 Electrophysiological properties of splice isoforms CaV1.3LF E31, CaV1.3LF E31E32 and 
CaV1.3LF E31aE32 compared to CaV1.3LF A2123V. A. Channel gating properties of CaV1.3LF A2123V 
reproduced from Figure 3.3A.  B. Gating profile for channel variant CaV1.3LF E31.  LF WT 
profiles were reproduced as gray dash curves from second through bottom panel.  
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The f-value and fractional recovery profile is not significantly different from LF WT as shown in the third panel. Activation and inactivation were not significantly 
different from the LF WT as shown in bottom two panels. C. Gating profile for channel variant CaV1.3LF E31E32. Format as in B. The f-value and fractional recovery 
profile unchanged. Activation and inactivation gating not significantly different from the LF WT, as shown in bottom two panels. D. Gating profile for channel 
variant CaV1.3LF E31aE32.  Format as in C. The f-value and fractional recovery profile unchanged. Activation and inactivation gating remain unaltered from LF WT. 
 
Table 3.1 Electrophysiological properties of CaV1.3LF A2123V channels in comparison with different splice variants  
 
 
Number of experiments is indicated in parentheses. V1/2act and V1/2inact represent potential of half activation of half inactivation. V1/2act was derived from either IV 
curve or Ba2+ tail-activation curves (Figure 3.3 and 3.4, bottom two panels) and V1/2inact was derived from Ba2+ steady state inactivation curve (Figure 3.3 and 3.4, 




Construct V1/2 act Vmax V1/2 inact f-value at r50 f-value at r300 
 IV  Tail IV SSI   
CaV1.3LF A2123V -34.04 ± 0.67 (18) -19.66 ± 1.42 (13) -12.67 ± 0.86 (18) -37.32 ± 2.43 (5) 0.20 ± 0.03 (8) 0.30 ± 0.04 (8) 
CaV1.3LF E8 -27.64 ± 1.04 (9) a -13.15 ± 1.43 (6) a -7.71 ± 1.21 (9) a -37.67 ± 1.58 (8) 0.18 ± 0.03 (5) 0.32 ± 0.03 (5) 
CaV1.3LF ΔE11 -24.84 ± 1.16 (8) a -3.45 ± 1.78 (7) a -3.25 ± 1.43 (8) a -37.47 ± 1.15 (6) 0.20 ± 0.02 (7) 0.39 ± 0.03 (7) 
CaV1.3LF E31 -32.86 ± 0.96 (15)  -20.08 ± 0.88 (10) -12.19 ± 0.95 (15) -39.04 ± 2.56 (6) 0.16 ± 0.01 (9) 0.29 ± 0.02 (9) 
CaV1.3LF E31E32 -33.42 ± 0.80 (9) -22.44 ± 1.33 (10)  -11.48 ± 1.07 (9) -39.02 ± 2.15 (7) 0.17 ± 0.02 (10) 0.28 ± 0.03 (10) 




Impact on DHP sensitivity due to alternative splicing in IS6 and I-II loop and domain 
IV of CaV1.3 
CaV1.2 and CaV1.3 are two L-type channel isoforms displaying distinct and 
overlapping expression patterns in neurons. Despite sharing 75% of sequence 
homology, CaV1.2 is almost twenty times more sensitive to DHP inhibition as 
compared to CaV1.3 (Xu and Lipscombe, 2001). Several domains that are required for 
DHP modulation have been identified in IIIS5, IIIS6 and IVS6 (Grabner et al., 1996) 
as highlighted in Figure 3.5A. While IIIS6 and IVS6 segment were shown by 
photo-affinity labeling to be responsible for DHP interaction, IIIS5 appears to be the 
action site for DHP modulation (Mitterdorfer et al., 1998). Mutational study further 
pin-pointed nine amino acid residues (Thr1039, Gln1044, Ile1153, Ile1156, Met1161, Tyr1463, 
Met1464, Ile1470, and Ile1471) locating in respective transmembrane segments to be 
crucial for DHP sensitivity (Sinnegger et al., 1997). Substituting corresponding amino 
acids into the DHP-insensitive α1A was shown to completely transfer the DHP 
sensitivity of CaV1.2 (Sinnegger et al., 1997). More drastically, study by He et al., 
1997 showed that Thr1039 to Tyr substitution in IIIS5 of CaV1.2 alone reduced the 
DHP sensitivity to more than 1000-fold. As highlighted in red in Figure 3.5B, the nine 
amino residues are almost conserved from CaV1.2 to CaV1.3 except for Ile1156 which is 
changed to valine in CaV1.3.  
Given the high degree of conservation in the molecular determinants of DHP 
modulation between the two channel isoforms, it is possible that other structural 
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domains outside IIIS5, IIIS6 and IVS6 segments account for the differences in DHP 
sensitivity between CaV1.2 and CaV1.3 channels. Supportingly, alternative splicing in 
the IS6 and IVS3 segments of the CaV1.2 channel was known to modulate DHP 
sensitivity with exon 8 and exon 31 conferring enhanced DHP sensitivity as compared 
to exon 8a and exon 31a respectively (Welling et al., 1997; Zuhlke et al., 1998). High 
sequence conservation was found in the mutually exclusive exons 8 and 8a, 31 and 
31a between CaV1.2 and CaV1.3 channels (Figure 1.2). In addition, CaV1.2 channels 
with inclusion of exon 32 in IVS3-IVS4 loop display faster voltage dependent channel 
inactivation correlating with higher sensitivity to DHP inhibition (Liao et al., 2007). 
This observation agrees with the widely accepted hypothesis that DHP preferentially 
binds to the inactivated channel and subsequently stabilizes the inactivated state (Bean, 
1984; Sanguinetti and Kass, 1984). However the exon 32 of CaV1.2 and CaV1.3 
channels share low sequence similarity (Figure 1.2).  
Here we examine the effect of alternative splicing on DHP modulation of 
CaV1.3 channels. As a first step, 5 μm nimodipine was used to block different CaV1.3 
splice isoforms including CaV1.3LF A2123V, CaV1.3LF E8, CaV1.3LF ΔE11, CaV1.3LF E31, 
CaV1.3LF E31E32, CaV1.3LF E31aE32. The concentration is close to the IC50 (2.7 ± 0.3 μm) 
of nimodipine inhibition on CaV1.3 current as reported by Xu and Lipscombe, 2001. 
As the baseline, Figure 3.6A displayed the profile for CaV1.3LF A2123V. Exemplar Ba2+ 
current before drug (top panel, black trace) evoked by depolarization to -10 mV 
showed little inactivation while 5μm nimodipine induced both the reduction of 
maximum current and rapid current decay. The extent of inhibition was quantified in 
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the next two panels. The normalized peak Ba2+ current before (black) and after (green) 
5 μm nimodipine is plotted against voltage in the second panel while fraction of peak 
current remaining with 5 μm nimodipine from -30 mV to 30 mV is shown in the third 
panel. The percentage of current remaining decreases from 56.4 ± 3.2% to 37.8 ± 
2.2% with increasing voltages from -30 to 30 mV indicating DHP inhibition is 
gradually enhanced with increasing depolarization. This trend appears to correlate 
with faster VDI with increasing voltages, represented by plotting r300 value (fraction 
of peak current remaining after 300 ms of depolarization) against voltage in the 
bottom panel. Such apparent correlation between DHP sensitivity and VDI again 
supports the state dependency of DHP inhibition.   
The CaV1.3LF E31 splice isoform bearing exon 31 displayed higher DHP sensitivity 
than CaV1.3LF A2123V as the percentage current remaining decreases from 47.0 ± 1.8 % 
to 30.1 ± 3.6% with increasing voltages from -30 to 30 mV (Figure 3.6B, third panel) 
while the VDI relation was not significantly different from CaV1.3LF A2123V (Figure 
3.6B, bottom panel). Statistically significant differences were highlighted by the red 
shading. Similar observations were made with CaV1.3LF E31E32 and CaV1.3LF E31E32 
where DHP sensitivity was heightened as compared to CaV1.3LF A2123V while VDI 
relation remains largely unaltered (Figure 3.6C and D, bottom panels). For CaV1.3LF 
E31E32, the percentage current remaining decreases from 36.5 ± 2.9 % to 20.5 ± 2.2% 
(Figure 3.6C, third panel) while percentage current remaining for CaV1.3LF E31E32 
changes from 38.9 ± 3.6 % to 25.7 ± 2.9% (Figure 3.6D, third panel) from -30 to 30 
mV. On the other hand, drug sensitivity was not significantly changed by alternative 
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splicing in the IS5-IS6 and I-II loop region as CaV1.3LF E8 and CaV1.3LF ΔE11 channels 
were inhibited by DHP to similar level as compared to CaV1.3LF A2123V (Figure 3.6E 

















Figure 3.5 Conservation of molecular determinants for DHP modulation between CaV1.2 and 
CaV1.3 channels. A. Hypothetical transmembrane topology of CaV α1 subunit. Structural domains 
shown to determine DHP sensitivity are highlighted in red including IIIS5, IIIS6 and IVS6 
(Grabner et al., 1996). B. Alignment of sequences coding for IIIS5, IIIS6 and IVS6 of CaV1.2 and 
CaV1.3 channels. Total nine amino acids detected to be essential for drug modulation (Sinnegger et 
al., 1997) are highlighted in red. Sequence difference is indicated by arrow. Numbering is 
according to a published α1C sequence (Genbank accession number M67515).
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Figure 3.6 DHP sensitivity of splice isoforms CaV1.3LF E31, CaV1.3LF E31E32, CaV1.3LF E31aE32, 
CaV1.3LF E8 and CaV1.3LF ΔE13 as compared to long-form wildtype CaV1.3LF A2123V. A. Sensitivity of 
CaV1.3LF A2123V towards 5 μm nimodipine.  Top panel, exemplar traces of currents evoked from 
holding potential of -90 mV to test potential of -10 mV, before (black) and after (green) 5 μm 
nimodipine.  Throughout, vertical scale bar pertains to current with 5 μm nimodipine. Second 
panel, normalized peak Ba2+ current before (black) and after (green) 5 μm nimodipine versus 
voltage relation. Currents of individual cell were normalized to peak current before 5 μm 
nimodipine before averaging. Third panel, percentage of peak current remaining after 5 μm 
nimodipine at each voltage.  Values were obtained by dividing the peak current before and after 5 
μm nimodipine. Bottom panel, VDI of the current before drug indicated by r300, fraction of peak 
current remaining after 300-ms depolarization to indicated voltages (V). For second through 
bottom panels, s.e.m. bars are shown when larger than symbol size. B.  Enhanced sensitivity of 
CaV1.3LF E31 towards 5 μm nimodipine. Statistically significant difference indicated by shaded 
region in the third panel. CaV1.3LF A2123V profile reproduced as grey curve. C. Enhanced sensitivity 
of CaV1.3LF E31E32 towards 5 μm nimodipine showing enhanced sensitivity towards DHP. Format 
as in B.  D. Enhanced sensitivity of CaV1.3LF E31aE32 towards 5 μm nimodipine. Format as in B. E. 
CaV1.3LF E8 displayed similar sensitivity towards 5 μm nimodipine as compared to WT. Format as 
in B. F.  CaV1.3LF ΔE11 displayed similar sensitivity towards 5 μm nimodipine as compared to WT. 
Format as in B.  
 
3.4 Discussion 
In addition to RNA editing, alternative splicing offers another versatile 
means of generating molecular diversity by creating different combinations of exons. 
A total of 14 alternatively spliced exons have been detected in α1D transcripts, giving 
rise to possibly millions of different combinations. However the actual number of 
splice variations is likely to be less as compared to the theoretical permutation, 
because the splicing event is probably not random, governed by the fact that tissue 
specific expression of different splice factors control the outcome of splicing 
(Licatalosi et al., 2008). Fittingly, some α1D splice variants are selectively expressed in 
a tissue and even species specific manner as summarized in Table 1.1.  
Here, we screened for splice variation of α1D transcripts, employing rat brain 
and heart cDNA libraries as templates and focusing particularly on IS5-IS6, I-II loop 
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and IVS3-IVS4 regions. Comparison of splice variation between rat brain and heart 
provide strong evidence of tissue selective processing of α1D transcripts. Firstly, while 
exon 8a was dominantly included in heart (Figure 3.1E, top), exon 32 was expressed 
to almost 100% in the brain (Figure 3.1D, top). Secondly, exon 9* which was first 
identified in rat cochlea (Ramakrishnan et al., 2002) was included at a very low level 
in both brain (Figure 3.1D, top) and heart (Figure 3.1E, top). In comparison, exon 11 
is expressed at the same level in both brain and heart. Interestingly, the presence of 
exon 9* correlated with the exclusion of exon 11 in brain (Figure 3.1D, bottom) while 
exon 9* always co-expressed with exon 11 in heart. Lastly, screening of the rat heart 
transcripts identified a new alternate exon, named as exon 31* here. Exon 31* is 
located between mutually exclusive 31/31a and exon 32 in the genomic sequence. The 
12-nucleotide exon with the sequence AAAATTGTAGCG codes for peptide sequence 
KIVA in the extracellular loop between IVS3 and IVS4 and was found to co-express 
with exon 31 (Figure 3.2E bottom). Notably, the intron immediately downstream of 
exon 31* was flanked by non-canonical GC-AG splice site which possibly entails 
different mode of processing by the splicing machinery in the heart tissue (Thanaraj 
and Clark, 2001). 
Functionally, alternative inclusion of exon 8 and exclusion of exon 11 
selectively shifted activation to more depolarized voltage while leaving the steady 
state inactivation property unchanged (Figure 3.3B and C, bottom panel and Table 
3.1). The channel activation of CaV1 and CaV2 channels is initiated by voltage 
dependent movement of voltage sensing domain, resulting in conformational change 
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which is subsequently coupled to the opening of S6 gate via the S4-S5 linker (Stary et 
al., 2008; Swartz, 2008). The distal part of four S6 segments constitute channel gate 
(Xie et al., 2005). Mutually exclusive exons 8 and 8a code for IS6 segment and part of 
IS5-IS6 loop facing the extracellular environment. Alignment of sequences of exon 8 
and 8a revealed six amino acid differences with four in the IS5-IS6 loop and two in 
upper part of the IS6 segment but not in the distal segment (Figure 3.7A). However, it 
could still be possible that structural differences conferred by exon 8 impede the 
movement of S6 gate which then requires higher voltage stimuli for equal channel 
opening, therefore shifting the activation of the channel to more positive potential.  
Similarly, deletion of exon 11 could also impose different structural 
conformations in the I-II loop region. The I-II loop domain harbors important motifs 
such as AID (alpha interacting domain) in exon 9 for interaction with β-subunits. 
Apart from enhancing channel expression (Altier et al., 2011), the binding of 
β-subunits regulates the activation and inactivation profile of the channel (Pragnell et 
al., 1994; Walker and De Waard, 1998). Although the detailed mechanism is still 
unknown, there is evidence that, β-subunits could also modulate the coupling between 
voltage sensing and gate opening (Walker and De Waard, 1998) given the proximity 
of the β-subunit to the S6 gate. Thus it would be interesting to test whether alternative 
splicing, in particular alternate inclusion or exclusion of exon 11, can further regulate 
such a process by changing the overall conformation of the I-II loop.   
Beyond the mechanistic speculation, depolarized-shifted activation property 
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observed with alternate inclusion of exon 8 and especially deletion of exon 11 
challenged the traditional view that CaV1.3 channels conducts only low 
voltage-activated current. The exclusive expression of exon 11 in only CaV1.3 may 
serve to explain the unique gating property of CaV1.3 distinct from other L-type 
calcium channels. Nonetheless, further characterization of exon 9* inclusion is also 
important to allow for full understanding of functional impacts of alternative splicing 
in I-II loop region.  
 In addition, functional characterization of splice variants in IVS3-IVS4 
revealed that exon 31 and 32 confer higher DHP sensitivity while preserving the 
gating properties of the channel (Figure 3.3 and Figure 3.6 A to D). Dominant 
expression of exon 32 in the brain (Figure 3.2D) could potentially sensitize brain 
tissues towards DHP inhibition. Given the fact that inactivation profile remained 
largely unaltered (Figure 3.5, second panel), alternative splicing in IVS3-IVS4 could 
impose different DHP sensitivity via modulating the interaction between drug and 
channel. Subsequent mutational study, by restoring the amino acid discrepancy 
between exon 31 and 31a would serve to uncover the sequence determinant for 
differential DHP modulation. An attractive target could be the asparagine (N) to 
aspartate (D) change from exon 31a to 31 in the IVS3-IVS4 loop (Figure 3.7B) 
whereby a neutral side chain is replaced with a negatively charged one. Similar 
mutation experiments could also be conducted in exon 32 to better understand its role. 
Lastly, the functional impacts of the newly identified exon 31* selectively expressed 
in the heart remains uncharacterized.  
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In summary, the study here uncovers compelling evidence that intrinsic 
properties such as hyperpolarized activation voltage and low drug sensitivity are 
heavily regulated by alternative inclusion or exclusion of alternatively spliced exons. 
This adds on to the previous findings that CaM-modulated CDI is regulated by 
extensive alternative splicing in the C-terminus domain (Shen et al., 2006; Singh et al., 
2008).  The presence of different spliceosomes with different processing capability 
unique to each tissue or cellular type could therefore flexibly determine the outcome 
of splicing, generating a tissue specific set of channel isoforms best suited for normal 
cellular physiology.     
 
 
Figure 3.7 Comparison of sequence differences between exon 8 and 8a, exon 31 and 31a of 
CaV1.3 channels. A. Alignment of exon 8 and 8a. Amino acid differences were highlighted in 
yellow. The transmembrane domain is indicated by overhead bold lines and labels. B. Alignment 






























The study here presents functional characterization of two types of 
post-transcriptional modifications of α1D transcripts including RNA editing and 
alternative splicing. Firstly, by comparing the genomic DNA and mRNA transcript 
of rat CaV1.3 channels, we observed three closely spaced edited sites in the IQ 
domain, a structural determinant which plays crucial role in Ca2+-feedback 
regulation of the channel. Interestingly, editing was tissue specifically regulated and 
was only observed in central nervous system including brain and spinal cord but not 
in peripheral tissues such a pancreas, heart or cochlea where CaV1.3 channels are 
also abundantly expressed. The IQ domain editing was later found to be mediated by 
ADAR2 enzyme as screening of α1D transcript in ADAR2-/- knockout mice brain and 
spinal cord failed to detect editing in the IQ domain. The editing is evolutionarily 
conserved from human, rat to mouse, governed by a highly conserved signature 
RNA duplex structure which serves as a substrate for ADAR2.  Functionally, IQ 
domain editing lead to substantial slow-down of calcium dependent inactivation 
which allows for prolonged influx of calcium current. Supportingly, SCN neurons of 
wildtype (ADAR2+/+/GluR-BR/R) mice displayed higher firing frequency of action 
potential firing and underlying calcium spikes as compared to ADAR knockout 
(ADAR2-/-/GluR-BR/R) mice, fitting closely with the effect of more sustained influx 
of calcium current near the threshold potential.  
The second part of the thesis characterizes the functional effect of alternative 
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splicing in three splicing hot spots including IS5-IS6, I-II loop and IVS3-IVS4 
regions. Colony screening experiment revealed different splicing patterns of α1D 
transcripts between rat heart and brain and helped identify dominant splice form in 
respective tissues. Whereas exon 8a was dominantly expressed in the heart, exon 32 
was included to almost 100% in the brain. In addition screening in the heart revealed a 
new exon 31* which added four amino acids to the extracellular IVS3-IVS4 loop. 
Subsequent electrophysiological characterization of different splice channel variants 
revealed that alternative splicing changed the activation properties and drug 
sensitivity of the channels. Specifically, inclusion of either exon 8 or exon 11 shifted 
the activation of the channel to more positive potentials while inclusion of exon 31, 
exon 32 or both exon 31 and exon 32 conferred higher sensitivity towards DHP 
inhibition.   
4.2 Future studies 
 Although the SCN neuron has been shown to rely on the CaV1.3 current for 
pacemaking, the difference between WT and ADAR2 KO SCN neurons could still be 
confounded by other still unknown ADAR2 targets, which also become unedited in 
the absence of ADAR2.  Firstly, isolating CaV1.3 mediated barium and calcium 
current from WT and ADAR2 KO SCN neuron to observe a faster CDI in KO as 
compared to WT mice would further strengthen the claim that the deficiency of IQ 
domain editing resulted in altered SCN rhythmicity in ADAR2 KO mice via alteration 
of channel inactivation properties. Secondly, with the identification of the important 
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sequence determinant such as ECS that is critical for the formation of RNA duplex to 
support editing of α1D transcripts, another goal in future is to generate transgenic 
mouse that is deleted of the ECS and thus has abolished editing specifically in the IQ 
domain of CaV1.3 channels. This could conclusively fill in the knowledge gap 
regarding the physiological roles of altered CaV1.3 channel properties as a result of 
such an editing event. Given the wide-ranging physiological roles of CaV1.3 channels, 
would functional knockout of RNA editing in IQ domain disrupt the rhythmic activity 
in also SNc neurons? Correspondingly, with faster inactivating CaV1.3 current, would 
there be altered motor function and would the mice be better protected against 
Parkisonian symptoms induced by chemicals such as rotenone?  In addition, would 
there be any behavioural changes, for example disruption of fear conditioning or 
altered circadian rhythm of feeding activity? Lastly, would there be any defects in 
development of neuronal circuitry or the release of neurotransmitters?  
As for alternative splicing, here, we use transcript scanning to detect splice 
variation. IS5-IS6 and I-II loop region and IVS3-IVS4 region were screened 
separately in this study.  However it is likely that alternative splicing is not 
independent of each other but linked; an example could be the inclusion of exon 9* 
coincided with the inclusion of exon 11 in the rat heart. Therefore in the future it 
would be important to create full-length cDNA libraries of the CaV1.3 channels from 
respective tissues. As alternative splicing in different functional modules of the 
channel regulates different channel properties, identification of tissue specific 
dominant full-length splice pattern would provide the ultimate answer as to how 
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